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GObjectives: To test the hypotheses that virtual
outreach would reduce offers of hospital follow-up
appointments and reduce numbers of medical
interventions and investigations, reduce numbers of
contacts with the health care system, have a positive
impact on patient satisfaction and enablement, and lead
to improvements in patient health status. To perform
an economic evaluation of virtual outreach.
Design: A randomised controlled trial comparing joint
teleconsultations between GPs, specialists and patients
with standard outpatient referral. It was accompanied
by an economic evaluation. 
Setting: The trial was centred on the Royal Free
Hampstead NHS Trust, London, and the Royal
Shrewsbury Hospital Trust in Shropshire. The project
teams recruited and trained a total of 134 GPs from 
29 practices and 20 consultant specialists.
Participants: In total, 3170 patients were referred, of
whom 2094 consented to participate in the study and
were eligible for inclusion. In all, 1051 patients were
randomised to the virtual outreach group and 1043 to
standard outpatient appointments. The patients were
followed 6 months after their index consultation.
Interventions: Patients randomised to virtual outreach
underwent a joint teleconsultation, in which they
attended the general practice surgery where they and
their GP consulted with a hospital specialist via a
videolink between the hospital and the practice.
Main outcome measures: Outcome measures
included offers of follow-up outpatient appointments,
numbers of tests, investigations, procedures,
treatments and contacts with primary and secondary
care, patient satisfaction (Ware Specific Visit
Questionnaire), enablement (Patient Enablement
Instrument) and quality of life (Short Form-12 and
Child Health Questionnaire). An economic evaluation
of the costs and consequences of the intervention was
undertaken. Sensitivity analysis was used to test the
robustness of the results.
Results: Patients in the virtual outreach group were
more likely to be offered a follow-up appointment.
Significant differences in effects were observed
between the two sites and across different specialities.
Virtual outreach increased the offers of follow-up
appointments more in Shrewsbury than in London, and
more in ENT and orthopaedics than in the other
specialities. Fewer tests and investigations were
ordered in the virtual outreach group, by an average of
0.79 per patient. In the 6-month period following the
index consultation, there were no significant differences
overall in number of contacts with general practice,
outpatient visits, accident and emergency contacts,
inpatient stays, day surgery and inpatient procedures or
prescriptions between the randomised groups. Tests of
interaction indicated that virtual outreach decreased
the number of tests and investigations, particularly in
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P Wallace,1* J Barber,1,2 W Clayton,1 R Currell,3 K Fleming,4 P Garner,5 A Haines,6
R Harrison,1 P Jacklin,6 C Jarrett,3 R Jayasuriya,1 L Lewis,3 S Parker,1 J Roberts,6
S Thompson7 and P Wainwright3
1 Department of Primary Care and Population Sciences, Royal Free and University College Medical School, 
London, UK
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5 British Telecom, UK
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* Corresponding authorpatients referred to gastroenterology, and increased
the number of outpatient visits, particularly in those
referred to orthopaedics. Patient satisfaction was
greater after a virtual outreach consultation than after a
standard outpatient consultation, with no heterogeneity
between specialities or sites. However, patient
enablement after the index consultation, and the
physical and psychological scores of the Short Form-12
for adults and the scores on the Child Health
Questionnaire for children under 16, did not differ
between the randomised groups at 6 months’ follow-
up. NHS costs over 6 months were greater for the
virtual outreach consultations than for conventional
outpatients, £724 and £625 per patient, respectively.
The index consultation accounted for this excess. Cost
and time savings to patients were found. Estimated
productivity losses were also less in the virtual outreach
group.
Conclusions: Virtual outreach consultations result in
significantly higher levels of patient satisfaction than
standard outpatient appointments and lead to
substantial reductions in numbers of tests and
investigations, but they are variably associated with
increased rates of offer of follow-up according to
speciality and site. Changes in costs and technological
advances may improve the relative position of virtual
consultations in future. The extent to which virtual
outreach is implemented will probably be dependent
on factors such as patient demand, costs, and the
attitudes of staff working in general practice and
hospital settings. Further research could involve 
long-term follow-up of patients in the virtual 
outreach trial to determine downstream outcomes 
and costs; further study into the effectiveness 
and costs of virtual outreach used for follow-up
appointments, rather than first-time referrals; and 
whether the costs of virtual outreach could be
substantially reduced without adversely affecting 
the quality of the consultation if nurses or other
members of the primary care team were to undertake
the hosting of the joint teleconsultations in place of 
the GP . Qualitative work into the attitudes of the
patients, GPs and hospital specialists would also be 
valuable.
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List of abbreviations
All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or 
it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices in which case 
the abbreviation is defined in the figure legend or at the end of the table.Objectives
Main trial: to test the hypotheses that virtual
outreach would:
  reduce offers of hospital follow-up
appointments 
  reduce numbers of medical interventions and
investigations
  reduce numbers of contacts with the health care
system
  have a positive impact on patient satisfaction
and enablement
  lead to improvements in patient health status. 
Economic evaluation: to test the hypotheses that
virtual outreach would:
  incur no increased costs to the NHS 
  reduce the costs incurred by patients attending
outpatient appointments 
  reduce the time taken off work
  be more cost-effective than physical outreach
clinics.
Methods
Design
The study was principally a randomised controlled
trial comparing joint teleconsultations between
GPs, specialists and patients with standard
outpatient referral. It was accompanied by an
economic evaluation. 
Setting
The trial was centred on the Royal Free
Hampstead NHS Trust, which serves GPs in inner
city and urban settings in London, and the Royal
Shrewsbury Hospital Trust in Shropshire, which
serves GPs and patients in small market towns and
rural settings. The project teams recruited and
trained a total of 134 GPs from 29 practices, 15 in
London and 14 in Shrewsbury, and 20 consultant
specialists. Of the latter, nine were in medical
specialities (gastroenterology 3, endocrinology 1,
neurology 1, general medicine 2 and
rheumatology 2), and 11 in surgical specialities
(ENT surgery 4, orthopaedics 2 and urology 5).
Subjects
All patients referred by the participating GPs to
specialists participating in the trial were included,
with the exception of patients requiring urgent
assessment, private patients and those with
significant difficulty communicating in English. In
total, 3170 patients were referred, of whom 2094
consented to participate in the study and were
eligible for inclusion, 862 in Shrewsbury and 1232
in London. In all, 1051 patients were randomised
to the virtual outreach group and 1043 to
standard outpatient appointments. The patients
were followed for 6 months after their index
consultation.
Intervention
Virtual outreach services were established in the
Royal Free Hampstead NHS Trust in inner
London and the Royal Shrewsbury Hospital Trust
in Shropshire. Patients randomised to virtual
outreach underwent a joint teleconsultation, in
which they attended the general practice surgery
where they and their GP consulted with a hospital
specialist via a videolink between the hospital and
the practice.
Main outcome measures
Outcome measures included offers of follow-up
outpatient appointments, numbers of tests,
investigations, procedures, treatments and contacts
with primary and secondary care, patient
satisfaction (Ware Specific Visit Questionnaire),
enablement (Patient Enablement Instrument) and
quality of life (Short Form-12 and Child Health
Questionnaire). An economic evaluation of the
costs and consequences of the intervention was
undertaken. Sensitivity analysis was used to test
the robustness of the results.
Results
Patients in the virtual outreach group were more
likely to be offered a follow-up appointment (odds
ratio 1.52, 95% confidence interval (CI) 1.27 to
1.82, p < 0.001). Significant differences in effects
were observed between the two sites (p = 0.009)
and across different specialities (p < 0.001).
Virtual outreach increased the offers of follow-up
Health Technology Assessment 2004; Vol. 8: No. 50
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Executive summaryappointments more in Shrewsbury than in
London, and more in ENT and orthopaedics than
in the other specialities. Fewer tests and
investigations were ordered in the virtual outreach
group, by an average of 0.79 per patient (95% CI
0.37 to 1.21 per patient, p < 0.001). In the 
6-month period following the index consultation,
there were no significant differences overall in
number of contacts with general practice,
outpatient visits, accident and emergency contacts,
inpatient stays, day surgery and inpatient
procedures or prescriptions between the
randomised groups. Tests of interaction showed
evidence of differences in effects by speciality for
number of tests and investigations (p = 0.01) and
outpatient visits (p =0.007). They indicated that
virtual outreach decreased the number of tests and
investigations, particularly in patients referred to
gastroenterology, and increased the number of
outpatient visits, particularly in those referred to
orthopaedics. Patient satisfaction was greater after
a virtual outreach consultation than after a
standard outpatient consultation (mean difference
0.33 scale points, 95% CI 0.23 to 0.43, p < 0.001),
with no heterogeneity between specialities or sites.
However, patient enablement after the index
consultation, and the physical and psychological
scores of the Short Form-12 for adults and the
scores on the Child Health Questionnaire for
children under 16, did not differ between the
randomised groups at 6 months’ follow-up.
Overall, NHS costs over 6 months were greater for
the virtual outreach consultations than for
conventional outpatients, £724 and £625 per
patient, respectively (difference in means £99, 
95% CI £10 to £187, p = 0.03). The index
consultation accounted for this excess. Cost and
time savings to patients were found (difference in
mean total patient cost £8, 95% CI £5 to £10, 
p < 0.0001). Estimated productivity losses were
also less (difference in mean cost £11, 95% CI £10
to £12, p < 0.0001) in the virtual outreach group.
Comparison with physical outreach clinics was not
carried out as the required data were not available. 
Conclusions
This trial demonstrated that virtual outreach
consultations result in significantly higher levels of
patient satisfaction than standard outpatient
appointments and lead to substantial reductions in
numbers of tests and investigations, but that they
are variably associated with increased rates of offer
of follow-up according to speciality and site. The
main hypothesis that virtual outreach would be
cost neutral is not supported, but the hypotheses
that patient costs and productivity losses would be
less were supported. Changes in costs and
technological advances may improve the relative
position of virtual consultations in future.
Implications for healthcare
These findings have important implications for
the design and implementation of virtual outreach
services within healthcare systems, and suggest
that appropriate patient selection, significant
service reorganisation, and provision of logistical
support for arranging and conducting
consultations will be required to enable such
services to operate efficiently. The extent to which
virtual outreach is implemented will probably be
dependent on factors such as patient demand,
costs, and the attitudes of staff working in general
practice and hospital settings.
Recommendations for research
The trial has answered many important questions,
but a number of additional issues of significant
importance would justify investment in further
research:
  The health service usage of patients in the 
6-month period following their index
consultation was assessed, but it is possible that
further benefits would have accrued over a
longer period. Further research could involve
long-term follow-up of patients in the virtual
outreach trial to determine downstream
outcomes and costs.
  Although virtual outreach appears to be of
limited effectiveness for unselected first-time
referrals, there is a real possibility that its
effectiveness would be significantly greater if it
were used predominantly for follow-up
appointments of patients. Further study into the
effectiveness and costs of virtual outreach used
for follow-up appointments, rather than first-
time referrals, is therefore recommended.
  The costs of joint teleconsultations in the trial
were high for a variety of reasons, but the
principal cost component was the initial
consultation, involving not only the consultant
and the patient but also the GP. Further study is
recommended into whether the costs of virtual
outreach could be substantially reduced without
adversely affecting the quality of the
consultation if nurses or other members of the
primary care team were to undertake the
hosting of the joint teleconsultations in place of
the GP. 
Executive summary
x  There is a strong suggestion from the trial
findings that the attitudes to the joint
teleconsultation of the patients, GPs and
hospital specialists all played a very important
part in determining outcomes, particularly in
relation to the offer of follow-up and patient
satisfaction. There is an important case for
undertaking qualitative work in this area. 
Health Technology Assessment 2004; Vol. 8: No. 50
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Within the NHS, the GP is essentially the
gatekeeper between the patient and secondary
care. Between 6 and 10% of patient episodes in
primary care result in a referral for a specialist
opinion, and as consultations in general practice
continue to rise, so referrals to secondary care in
England rose by more than 40% between 1987
and 1998.1 This rising trend may be attributed to
factors including an ageing population,
developments in medical technology and
therapeutics, increasing medical specialisation and
growing patient expectations, but it brings many
problems in its wake. There are particular
difficulties in communication between primary
and secondary care, patient satisfaction with the
consultation and referral process, and the ability
of health services to meet ever increasing
demand.2–4 One response is to attempt to provide
as much care as possible in the primary care
sector,5,6 which raises further issues of continuing
professional education and appropriate skill mix
amongst healthcare workers. The relationship
between practitioners in primary and secondary
care is pivotal in all of this. 
One approach to this problem has been to
investigate the ‘appropriateness’ of referrals from
primary to secondary care,7–10 but this has proved
to be an elusive and immeasurable concept. 
The reasons why GPs refer to secondary care 
have been categorised by Coulter and colleagues11
as: 
  to establish diagnosis
  for specific investigations
  for treatment or operation
  for advice on management
  to take over management
  to reassure the GP or the patient.
Poor communication at referral may impair the
quality of care provided, resulting in overuse of
healthcare resources, such as the unnecessary
ordering of tests or duplication of treatment, and
can contribute to the risk of iatrogenic damage. It
may also lead to lack of information, an underuse
of tests and delays in treatment, and patients may
suffer as a result. Despite the importance of this
topic, there is a dearth of reliable data available
about the influence of the quality of
communication between GPs and other primary
care professionals. In a Cochrane systematic review
by Zwarenstein and Bryant, no studies in primary
care were found.12 A number of observational
studies on written correspondence found that
communication of relevant patient data was
frequently inadequate, if not absent. Westerman
and colleagues, for example, found that referral
letters by GPs were prompt, but more than half
contained insufficient information.13 Discharge
information by specialists, although usually
comprehensive and complete, often arrived too
late or not at all.14 In one Spanish study, GPs
received a discharge letter in only one-quarter of
cases.15 In another, specific questions raised in
referral letters to orthopaedic surgeons were
answered in only 44% of cases.16 In his study,
Jenkins found a clear relation between the quality
of the information provided and the
appropriateness of the referral, with the
percentage of inappropriate referrals being
highest in referral letters with the least
information.17 Improved communication has been
demonstrated in a hospital setting to have a clear
effect on several process outcomes, such as the
length of stay after hospital admission. Although
these data came from hospital care, the findings
may be relevant to primary care as an example of
what can be achieved when the level and quality of
communication are improved. 
Improving communication at the
primary–secondary care interface
There have been many attempts to improve
communication. Some of these were designed to
improve the quality and comprehensiveness of the
information provided at the time of patient
referral. Others were meant to provide innovative
alternatives to the current standard forms of
consultation. 
Standardised referral letters
Various attempts have been made to improve the
quality of paper-based communication by
organising and structuring the content of letters.
Health Technology Assessment 2004; Vol. 8: No. 50
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Chapter 1
BackgroundIn several countries, structured referral letters
were developed, including recommendations
about what a good referral letter should contain.
One example is the standard referral letter
developed by the Dutch College of General
Practitioners.18 It is likely that communication will
benefit from referrals containing such data.
However, despite the general consensus about the
contents of a good referral letter, evidence about
the effects on the quality of communication is
absent. As lack of time is likely to be the principal
reason preventing doctors from providing
information at the appropriate level of detail to a
colleague, more effective implementation
strategies are needed to stimulate the use of
standard referral letters.
A prototype referral letter should contain as a
minimum:18
  personal information about the patient 
  doctor identification 
  signs and symptoms of the patient 
  the reason for referral. 
In case of referral to a non-surgical speciality,
information should be added:
  data such as test results
  drug use
  family history.
Patient-held records
Where the exchange of information between one
healthcare professional and another is
problematic, it is conceivable that more efficient
data exchange can be achieved when the data
accompany the patient. A good example is the
patient-held medical record. The patient-held
record has been tried out extensively for many
years and several benefits are described in the
literature, varying from indirect positive effects on
the health of patients (e.g. through better
adherence to preventive care) to time-savings.19,20
It seems especially valuable in cases where
multiple institutions or healthcare workers are
needed, such as in antenatal care, oncology and
palliative care.21,22 Clear-cut effects of the patient-
held record on the quality of communication have
so far not been found, owing, at least in part, to
the absence of sufficient randomised trials
focusing on this subject.23
Educational initiatives and the use of
guidelines
Ensuring that GPs are kept up to date with best
practice in the whole range of medical specialisms
is an almost impossible task. Thomson O’Brien
and colleagues24 reviewed the effectiveness of
continuing education meetings and concluded
that whereas teaching sessions alone are unlikely
to make professionals change their practice,
interactive workshops could have an effect. In a
similar review of printed educational materials,
Freemantle and colleagues25 found small and
uncertain effects, and Thomson O’Brien and
colleagues,26 reviewing audit and feedback as an
educational method, concluded that this could
have a small effect, but should not be relied on
alone. The effectiveness of local opinion leaders
was also found to be unclear.27 Clinical guidelines
have been used in many specialities with the 
object of improving practice and the
appropriateness of referrals to secondary care.
Davis and colleagues28 concluded that clinical
guidelines could be effective in changing
professional practice, but suggested that how they
were developed and implemented affected their
effectiveness. Woolf and colleagues29 draw
attention to the limitations of guidelines and to
the potential for harm, and studies of guidelines
in specific areas show not only that they may be
ineffective at reducing inappropriate referrals (e.g.
O’Brien and colleagues30) but also that they may
not be adhered to even on the secondary care side
of the interface.31 Clinical guidelines are 
designed for a particular patient group on a
population basis, and can thus be difficult for
general practitioners who deal with individual
patients. 
Outreach clinics
One way of providing expert advice to the GP for
an individual patient is through specialist outreach
clinics and domiciliary visits. Outreach clinics held
in GP surgeries or in community hospitals have
advantages for patients by usually being closer to
home with less time and expense spent on
travelling, and being in more familiar
surroundings, in an environment and with staff
that they already know.32 It is important to
distinguish between outreach clinics in which
specialist and primary care physician consult
jointly (either in the presence of the patient or
not) and peripheral clinics in which only primary
care premises are used and the GP is not present.
Benefits for clinicians cannot be expected in this
case. Reviews of outreach clinics in primary care in
the UK33,34 have shown that patients preferred
outreach appointments to hospital appointments,
and that their costs were less, while costs to the
NHS were increased, as specialists tended to see
fewer patients than in hospital clinics and spent
time travelling. The research does not show
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although it is believed that there is an educational
element for GPs, this has not been consistently
demonstrated in studies of conventional outreach
clinics, partly because it is not clear how actively
GPs participate in these sessions in reality. 
Joint consultation
The joint consultation was developed as an
alternative to standard outpatient referral for a
specialist opinion. In joint consultations, the GP
can include cases where there is doubt in both
directions, as whether to diagnose and treat the
patient him or herself or whether to refer the
patient. A joint consultation may also be desired in
cases where the GP would require the advice of the
specialist owing to a relative lack of expertise,
skills or knowledge. Real-time joint medical
consultations were shown in The Netherlands to
result in major reductions in unnecessary
investigations and treatments, and to reduce
substantially the need for hospital outpatient
follow-up. Joint consultations were developed as
an alternative to standard outpatient referral for a
specialist opinion, especially for cases where there
is doubt about whether diagnosis and treatment
can effectively be carried out in general practice.
In The Netherlands, a series of studies was carried
out on joint consultations between GPs and a
variety of different specialists.35,36 In the
Maastricht studies series, the joint consultations
were organised as a monthly meeting between a
group of four or five GPs with one specialist in the
practice of one of the GPs. During the monthly
1.5-hour sessions, each GP could bring in one or
two patients. These patients were reassessed in the
practice, together with the other GPs and the
consulting specialist. Such consultations were
organised with orthopaedic surgeons,
cardiologists, dermatologists and rheumatologists.
Overall, the acceptance of the joint consultations
was high, and they appeared to have a direct effect
on the management of the patient and
communication. First of all, as a result of a
learning effect and a higher level of skills, the
joint consultations were shown to reduce the
number of patients referred to specialist care.
After joint consultations between GPs and
orthopaedic surgeons the number of patients
referred was halved. In a study of joint
consultations between GPs and cardiologists, the
reduction was only 10%. Apart from these
findings, there are communication and
educational aspects of joint consultations. On the
basis of questionnaires about communication it
seems as if GPs and specialists sometimes appear
to talk a different language. Data as yet
unpublished show that there were clear differences
in the interpretation of the reason for referral. In
cases of routine referral to outpatient clinics, GPs
had a significantly different reason for referral to
that perceived by the specialists. This may have
been caused by lack of information or by
differences in interpretation. Joint consultations
may be useful in tackling this communication
problem, for after a joint consultation, the
interpretation of the reason for referral, or more
specifically, the difference between the GP’s reason
for referral and that perceived by the specialist,
clearly diminished.
‘Real-time’ videoconferencing
The transmission of images through electronic
networks can be achieved either as real-time
transmission of moving pictures, or through ‘store
and forward’ transmission of fixed images. These
may be X-rays and other radiological
investigations, or actual digital photographs,
preferably of high resolution. Usually, there is a
physical distance between primary and secondary
care, and it is the patient who is expected to cross
it. Dissatisfaction with travelling long distances for
long waits and brief consultations in hospital
outpatient clinics is well documented.
Videoconferencing technologies allow virtual
meetings between patients and practitioners, and
several studies have investigated such joint
teleconsultations in a range of clinical areas
including dermatology, orthopaedics, cardiology
and psychiatry.37 The introduction of
videoconferencing technologies and their
application to healthcare has provided a means of
overcoming distance, and created possibilities for
new solutions to long-standing problems in the
provision of health services. Videoconferencing
has been in use in medicine since the late 1960s.
Dwyer (1973),38 for example, described the use of
“interactive TV” for consultations with psychiatric
patients, reporting that he had been “delightfully
surprised” that the skills he used in a psychiatric
interview were not diminished or lost. He also
commented that some patients found the
experience easier than a routine face-to-face
encounter with a psychiatrist. Studies of
telemedicine have since progressed from such
early feasibility studies to studies of diagnostic
accuracy,39–41 and then to very many reports of
case series around the globe (e.g. Harno42).
Studies have reported high levels of patient
satisfaction, although the validity of these findings
has been questioned.43 More recently, several
reviews of the telemedicine literature have been
undertaken44–46 and they have all highlighted the
dearth of rigorous experimental studies examining
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and teleconsultation in particular, and the lack of
comprehensive economic evaluations. It is not
clear why telemedicine has not yet been subjected
to the same detailed assessment that is now
expected of all other forms of health technology.
There are several possible reasons. Telemedicine
has historically been introduced by a few
enthusiasts in a region or a discipline, and projects
have withered as funding has run out or the
innovator has moved on. There has now been a
telemedicine project somewhere in the world in
just about every medical speciality, which means
that early experience has been spread very thinly
and this has possibly made it difficult to put
together clinical trials with sufficient numbers of
participants. The organisational complexities of
telemedicine have been reported,47 particularly
the difficulties of scheduling two doctors and the
patient to be available at the same time. The
technology used in telemedicine applications has
changed dramatically over the years, so that now
the necessary equipment can be contained in a
desktop computer with an inexpensive web
camera. This has presented the classic problem in
health technology assessment, of when to assess
fast-moving technologies. Communication
technologies are only enabling technologies, and
are not interventions or treatments in themselves,
and comparisons with the telephone may have led
some to believe that rigorous assessment was not
necessary. However, telemedicine applications do
have the potential to alter radically the ways in
which healthcare services are organised and the
experience of healthcare for both patients and
professionals.
The Virtual Outreach Project offered the potential
to make use of the most effective of the existing
methods of supporting primary–secondary care
referral, through the medium of the latest
information and communications technology, and
to test its effectiveness. The virtual consultation
brings the local expert and GP face to face,
provides the opportunity for immediate feedback
on the current (and also previous) referrals and
allows interactive teaching. Whether or not a
structured or electronic referral letter has been
used, the virtual consultation enables the
immediate exchange of clinical data that may be
held by either the primary or secondary care
physician. Where guidelines or protocols are being
followed, these can be explained and
demonstrated on a case-by-case basis. The three-
way consultations in the Virtual Outreach Project
also put the patient at the centre of the episode,
with demonstrable continuity of care across the
interface, and the potential use of an advocate in
either the GP or the specialist. The literature on
all these topics makes it clear that the research
base for all the interventions designed to improve
care at the primary–secondary care interface (in
addition to the telemedicine research base) is
limited. Morrison and colleagues31 stated that:
“Relatively few studies of interventions to improve
referrals exist. Further studies are needed,
especially to explore methods of engaging both
primary and secondary care.” The Virtual
Outreach Project aimed to address some of these
issues. 
Development of the project: pilot
cluster randomised controlled
trial
In 1997/98, a pilot study was carried out in
preparation for a full-scale randomised controlled
trial (RCT).48 Four inner-city practices with
registered populations ranging from 7800 to
10,300 were recruited into the trial. Nine GPs
within the practices participated, but as several
only worked on a part-time basis, this amounted to
5.5 whole-time equivalents (WTE). At the Royal
Free Hospital the specialities included in the trial
were orthopaedics, ENT, gastroenterology, urology,
paediatrics and endocrinology, with one consultant
from each speciality participating for the duration
of the study. After discussion with the participating
practices it was agreed that all of the patients
whom they referred, within the specialities on
offer and for the duration of study period, should
be subject to randomisation. The administrative
arrangements to facilitate the process were as
follows. For the duration of the study all the
referral letters from the participating GPs to the
outpatient department at the Royal Free Hospital
were redirected initially to the Teleclinic office.
This design obviated any temptation on the part
of the GP to allocate (or withhold) patients from
the experimental service selectively, leaving the
choice to the patients themselves. Referrals not
included in the trial, because they did not relate to
consultants in the study, were immediately
redirected to the routine outpatient service.
Eligible referrals were then screened by a research
clinician to ensure that they met the entry criteria.
The entry criteria were:
  a routine referral primarily for diagnosis
  a referral primarily for advice about
management where decisions could be made on
the basis of history and tests
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have direct access (e.g. a magnetic resonance
imaging scan or an endoscopic examination)
  not an emergency referral where any time delay
was critical (it is unlikely in any case that urgent
referrals would be made by letter).
The videoconferencing was accomplished using
ISDN2 lines together with off-the-shelf
videoconferencing equipment, namely the British
Telecom VC8000 using Olivetti communications
software. This kit was fitted into a standard
desktop personal computer (PC). The standard
equipment was enhanced by the use of a call port,
making it unnecessary to use the telephone
handset. The experience of joint teleconferenced
consultations could be expected to have a
cumulative educational impact on the
participating GPs and therefore a potential
influence on their clinical performance, leading to
possible changes in the management of patients in
the control group. It was therefore decided to
randomise at the level of the GP rather than the
patient. The two main choices were to randomise
by GP practice or by individual GPs. Randomising
by GPs ran the risk of contamination from GPs
sharing information within the practice.
Randomising by practice would have incurred a
much heavier penalty by way of sample inflation,
as the cluster effect would have been greater for
practices than for individual GPs. There would
also have been little incentive for practices to take
part if they were not to receive the new service. It
was decided therefore to randomise GPs. This was
achieved through a system of balanced
randomisation. Balanced randomisation was
chosen because it provided for an even allocation
of practitioners to each speciality. Each GP was
assigned by means of a random number table to
one line in the matrix. Thus, the GP was involved
in virtual outreach in half of the trial specialities,
while in the other half, his or her patients were
seen in conventional outpatient clinics. Balanced
randomisation was achieved by assigning each GP
a number. Eligible patients were then assigned to
control or intervention group according to the
allocation given to the referring GP in a balanced
randomisation process. Thus, consenting patients
were allocated into a control group, which received
a conventional current best practice outpatient
service, or an intervention group, which consulted
the hospital specialist together with their GP by
means of a real-time videoconference at the GP’s
surgery. This was referred to as virtual outreach
clinic, with joint teleconferenced medical
consultations. All the patients in the control group
attended the Royal Free Hospital. The patients in
the control group saw the specialist alone unless
accompanied by a carer or relative. Carers and
relatives may have been present in addition to the
GP during the course of teleconsultation at the
GP’s surgery. Following assignment to control and
intervention groups consent was sought from
patients. Only those who were assigned to the
teleconsulting group (intervention group) were
sent an explanation of teleconsulting, using a
method described by Zelen.49 Patients in the
control group were asked only if they would
participate in a research project that would involve
completing some questionnaires and allowing the
research team access to their medical records.
The following instruments were used in the pilot
study:
  a demographic and personal details
questionnaire for patients
  the Short Form-12 (SF-12), a generic measure of
well-being
  the Ware Specific Visit Questionnaire (SVQ), to
measure patient satisfaction
  the Spielberger State Trait Anxiety Inventory
(STAI)
  a cost questionnaire for patients
  the Duke Severity of Illness (DUSOI)
questionnaire, to measure the co-morbidity or
burden of illness
  a protocol specifically designed to extract data
from hospital and GP records.
The instruments chosen to measure the key non-
economic variables had all been validated in
previous studies. Other data collection instruments
used to gather more immediate information, such
as economic data and health service usage, were
adapted from measures used by other health
service researchers, or developed specifically for
the virtual outreach study and piloted during the
previous year. 
On entry into the trial, and concurrent with
gaining the patient’s consent, the initial
questionnaire covering demographic information
and containing the SF-12 was dispatched. The
DUSOI was sent to the patient’s GP. Immediately
after the patient’s consultation a second
questionnaire was dispatched. The second
questionnaire contained the Ware (SVQ), the
Spielberger (STAI) and the economic questions.
After 3 months (the longest period permitted in
the pilot study) the SF-12 was sent again. To
maximise response rates all questionnaires were
subject to up to three reminders plus a personal
telephone call, when the referral letters provided
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the data collection process was accomplished by
means of a specifically designed management
database system using Microsoft Access.
It was decided to select a reduction in outpatient
follow-up appointments as the principal trial
outcome on which to calculate the sample size.
The study of Vierhout and colleagues35 indicated a
reduction in the number of patients receiving
follow-up appointments from 60% for routine
outpatients to 40% for joint consultations.
Assuming that virtual outreach would lead to a
reduction of the same magnitude, and ignoring
initially the implications of cluster sampling
resulting from the trial design, it was calculated
that for each speciality, 130 patients would need to
be included in the intervention group and 130 in
the control group to give the trial a 90% power to
detect a change of this size with a result significant
at the 5% level.50 To take account of the cluster
effect, an approximation of sample size inflation
of n(rn+1) was used, where r is the intraclass
correlation and n is the number of subjects per
cluster. Previous studies indicate that the intraclass
correlation is unlikely to be greater than 0.05.
Assuming recruitment of 45 GPs , each GP would
have to recruit some six referrals per speciality to
achieve 130 control and 130 intervention patients.
For each speciality in the main trial, the cluster
inflation factor would be 6 × (6 × 0.05 + 1) = 7.8.
This meant that the main trial would need to
include (45 × 7.8) = 351 referrals per speciality.
Assuming that each GP would on average make
one referral per month per speciality, it was
calculated that a period of 8 months would be
required to complete recruitment of an adequate
sample (45 × 8 = 360). 
A small amount of data was collected, but with a
total achieved sample size of 101 (49 interventions
and 52 controls), from six specialities, the sample
was insufficient for statistical outcome with any
acceptable power. The pilot study produced a
referral rate of 1.1, rather than the anticipated
1.5. Following some teething troubles, largely due
to misunderstanding within the practices about
what documents were to be sent, the
administration system worked well. In particular,
the practices were able to redirect all of the
referral letters to the Teleclinic research office
without problems. The letters were processed by
the research team within 24 hours, with
subsequent allocation to routine outpatient
attendance or teleconsultation. A figure of 1.1
eligible referrals per week per WTE GP was
achieved. In total, 439 referrals were received over
the trial period of 5 months from 5.5 WTE GPs.
Of the 439 referrals, 297 were not eligible to enter
the trial because they did not fall within the
specialities or consultants included in the trial. Of
the remaining 142 referrals, four cases were
excluded before scrutiny by the research team
because:
  the consultant was ill and the GP opted to have
the patient seen by junior staff
  the patient was admitted to hospital via accident
and emergency
  the patient was classified as urgent by their GP
  the patient was a paediatric case for whom the
GP requested a conventional outpatient
appointment.
Two cases excluded after scrutiny by the research
team were:
  an infant with clicking hips and a previous
missed diagnosis in the family
  an elderly women who was both blind and deaf.
A further four patients were lost to the trial
because they went for a private consultation or
declined consultation because they had recovered
or had occupational demands. Of the 132 referrals
entering the trial, 62 were for the intervention
group and 70 for the control group. Consent to
participate in the experimental arm of the trial
was obtained for all but 13 patients assigned to the
intervention group and 18 assigned to the control
group. A number of patients were lost to the trial
owing to incorrect addresses on referral letters.
Cancellation of appointments created a
considerable amount of extra work, particularly in
the case of the teleconsultations which required
three-way participation of GP, consultant and
patient. 
Response rates to the various questionnaires
ranged from 100 to 73%. The overall response
rate was misleading, however, as the item non-
response, that is patients not answering particular
items or questions within a particular
questionnaire, was higher. For two of the
questionnaires any item non-response meant that
the whole questionnaire was void. The STAI was
not fully completed by 12% (n = 16) of
respondents. The non-completion rate was slightly
higher among the intervention group than among
controls. Non-response tended to be among the
older patients (65 years plus) or for young
children. Two per cent (n = 3) of respondents did
not fully complete the SF-12, rendering their total
score void. The DUSOI was completed by the GPs
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completion rate of 90% was achieved for the
DUSOI. Non-response seemed to occur because
some GPs allowed backlogs to build up.
The pilot study demonstrated the effective
operation of a methodology designed to ensure
the non-selective recruitment of adequate
numbers of appropriate subjects to an innovative
health service, namely a teleconferenced medical
consultation. The allocation of patients directly
from routine referral letters written by the
participating GPs, resulted in the successful
recruitment of adequate numbers of non-selected
patients to the trial, and the balanced
randomisation achieved a reasonable distribution
between the experimental and control arms of the
study. A slight imbalance between the intervention
and control groups may have resulted from an
asymmetry in the referral rates from one or two
GPs. GP referral rates are known to vary quite
considerably,51 and this type of imbalance would
be less likely with a larger group of GPs. The
slightly lower referral rate of patients to the
specialities included in the trial of 1.1, rather than
the expected 1.5 per week WTE GP, probably
resulted from having to use GPs in the pilot who
did not exclusively use the Royal Free Hospital.
Thus, many of their referrals were not eligible for
inclusion in the study. An additional factor was
that not all of the consultants in the study
specialities were participants in the trial. As might
have been expected, referral rates across
specialities were not even. All but six (5%) of the
referrals came from gastroenterology, ENT,
orthopaedics and urology. With around 45–50 GPs
in a trial, these four specialities were deemed to be
capable of furnishing an adequate sample within a
manageable time scale of 8 months to 1 year. The
efficiency of sample recruitment could be
increased further. A number of patients, around
10% in each group, had an incorrect address on
their referral letter. This could have been
improved by tactful advice to general practices in
the initial training. Indeed, there were important
service implications as an incorrect address must
have been responsible for a significant proportion
of non-attendance at NHS outpatient clinics. It
was recognised, however, that patients may
deliberately withhold their correct address in
order to appear to remain with a practice
catchment area. All the research instruments
functioned well, apart from the STAI. There was a
high level of item non-response, that is, only
partial completion of the questionnaire. In total,
12% of the returned questionnaires were either
not completed or only partially completed,
rendering them void. Some of the non-response
group were children. A substantial proportion of
the remainder were elderly (65 years plus). The
particular Spielberger inventory used was also
designed to be completed very soon after the
event to which the level of anxiety measured may
have related. As the questionnaires that were
completed were frequently only returned after
reminders were dispatched, this was clearly 
not the case. The score therefore may have 
been quite arbitrary. In light of these
shortcomings it was decided not to use the STAI in
the main trial. 
The methodology had some limitations. As with
any trial of a new health technology incorporated
into the treatment process, it was not possible to
blind GPs to the patients’ allocation. It was
therefore possible in theory for the GPs to
manipulate the referrals by referring to another
hospital or withholding their referral letter from
the batch sent via the Teleclinic. Scrutiny of the
referral letters in the practices suggested that this
did not happen to any noticeable degree. The
method of sample recruitment also meant a loss of
control for GPs. They did, however, at all times
have the right to override the research office
allocation. Trials of health service innovations
cannot mirror actual practice and by their very
nature there is always forced choice in
experimental design. In practice, the participating
GPs managed to live with the arrangements quite
well, and only on two occasions asked for patients
to be withdrawn from the trial. In one case the
patient was an emergency and did not meet the
entry criteria, in any case. Overall, the pilot 
study demonstrated the effective operation of the
trial methodology designed to ensure the non-
selective recruitment of adequate numbers of
appropriate subjects to an innovative health
service. 
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An RCT was designed to assess the effectiveness of
joint teleconsultations (virtual outreach) compared
with standard outpatient consultations, across a
variety of specialities and in both urban and rural
settings. Ethical approval was granted by the
relevant local research ethics committees. 
The hypotheses to be tested were derived from
exploratory work carried out before the trial, and
from the studies published elsewhere, notably the
trial of joint consultation clinics carried out in
Maastricht. Although the Maastricht study had
demonstrated that the participating GPs had
improved their knowledge and skills of
orthopaedics, and apparently changed their
referral behaviour, it was decided not to evaluate
the impact of involvement in virtual outreach on
the clinical skills of the participating doctors, for a
number of reasons. This was because the GPs
involved in the study, particularly those in
Shropshire, did not want a cluster design because
they wished to develop overall experience of the
virtual outreach referrals in all the specialities that
were included in the trial. The steering group
discussed this proposal at length, given that a
decision to abandon the cluster design implication
would mean that it would no longer be possible
systematically to assess the impact of virtual
outreach on the clinical skills and referral
behaviour of the participating GPs. In the end it
was decided that it was essential to keep their
cooperation, and that the change in design would
not threaten the integrity of the research, as it was
unlikely that there would be contamination of the
control group in view of the limited number of
patients in each speciality per individual GP. Thus,
it was relatively unlikely that GPs would learn so
much about the management of specific cases
from a virtual outreach consultation that the
knowledge would influence the management of
similar cases randomised to the control group. In
addition, the individual randomisation had the
advantage that it increased the statistical power
compared with a cluster design. 
The proposal to change the study design was fully
discussed with the HTA programme directors, 
who gave their agreement to this change in the
study design.
Very little has been published on the cost-
effectiveness of teleconsultation, that is, real-time
consultations, where doctors and patients are
separated geographically but communicate
through the use of videoconferencing or some
other communication technology.52 An RCT
comparing conventional hospital consultations for
dermatology with real-time teledermatology
suggested that, subject to certain caveats about
travel distances and prices, conventional hospital
dermatological care remained the more cost-
effective option.53 A recent report of a systematic
review commented on the poor quality of studies
on the economic effectiveness of telemedicine and
found that there was no evidence that telemedicine
was cost-effective.54 The economic evaluation of
the Virtual Outreach Project was therefore a
potentially important addition to this literature.
The economic evaluation was undertaken to assess
the key costs and consequences of joint
teleconsultation. 
The current mode of referral and specialist
consultation may not be economically efficient as
there is considerable duplication of investigations,
unnecessary hospital follow-up, and concomitant
dissatisfaction among patients and clinicians.55,56
Although a joint teleconsultation, involving two
clinicians instead of one, is likely to be more
expensive than its conventional outpatient
counterpart, improved patient management may
potentially lead to net downstream savings to the
NHS. However, the case for joint teleconsultation
does not rest solely on such a narrow cost
minimisation approach. 
From a broader societal perspective, the joint
teleconsultation has the potential to reduce the
costs to patients of a specialist appointment 
(a ‘shadow cost’ of using an NHS ‘free at the 
point of delivery’), with concomitant increases in
economic productivity. Furthermore, new
healthcare technology is often cost-increasing, 
but can still be considered cost-effective providing
the additional benefits outweigh the additional
costs.
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Chapter 2
MethodsSelection of the principal sites
The Virtual Outreach Project was established
around two referral centres, one at the Royal Free
Hospital NHS Trust, a teaching hospital in
London, and the other in the Royal Shrewsbury
Hospital, a district general hospital in the market
town of Shrewsbury, serving a largely rural and
semirural community. The rationale for choosing
such different settings was to enable the
assessment of any systematic differences in the
impact of virtual outreach in rural settings, where
patients had to travel greater distances, and in the
urban context, where the separation between
home and hospital was smaller. 
General practitioners
The doctors who participated in the trial are
summarised in Table 1. The project teams in both
London and Shrewsbury had already established
good links with local GPs and consultants through
their previous involvement with telemedicine
projects. However, the trial required a different
level of involvement and larger numbers of GPs
than had previously been used. Letters were
therefore sent to GPs who were located within the
catchment area of the hospitals. The sample was
selected on the basis of evidence of substantial
levels of referral, whether or not they were group
practice allowing equipment to be shared, and
whether or not the practice had the space to house
videoconferencing equipment. GPs who elected to
participate in the trial had to agree that all their
referrals, not just those within the specialities
included in the trial, were routed via the Virtual
Outreach Office. The project teams recruited and
trained a total of 134 GPs from 29 practices, 15 in
London and 14 in Shrewsbury. A subsequent study
demonstrated that the participating GPs were
representative of their peers in their use of
information technology (IT).57
Consultants
In total, 20 consultant specialists were recruited
across the two sites. Of the latter, nine were in
medical specialities (gastroenterology 3,
endocrinology 1, neurology 1, general medicine 2
and rheumatology 2), and 11 in surgical
specialities (ENT surgery 4, orthopaedics 2 and
urology 5). 
Training
A training programme was designed for both the
GPs and the hospital specialists. In the first place,
a manual was produced (Appendix 1) to illustrate
how the equipment should be used, together with
a 10-minute videotape showing the complete set
of processes involved in the joint teleconsultation.
Two training weekends were held, one in
Birmingham (primarily for the Shrewsbury
participants) and one in London for those
working in the Royal Free project. Here, the
participants had the opportunity not only to try
out the equipment and to see how it felt to have a
joint consultation, but also to share fears,
expectations and general views with fellow GPs
and consultants alike. Shortly before the start of
recruitment phase of the trial, the research nurses
in both the Royal Free and Royal Shrewsbury
centres visited each of the participating practices,
to provide them with the materials and show them
exactly how the equipment could be used. They
were also present to help with the first few
teleconsultations undertaken by each GP and
hospital specialist, and a technical helpline was
established at each site to provide support to the
participating clinicians. There were varying
degrees of self-sufficiency among the participants,
and these were particularly marked in the hospital
specialists; some were ‘self-catering’, while others
required a ‘waiter service’. 
Establishment of virtual outreach
service
Virtual outreach services were established at the
Royal Free Hampstead NHS Trust, which serves
GPs in inner city and urban settings in London,
and at the Royal Shrewsbury Hospital Trust in
Shropshire, which serves GPs and patients in small
market towns and rural settings. To ensure
comparability, waiting times of no more than 
8 weeks were established for patients in both arms
of the trial. In most cases, the specialists were
unable to provide dedicated virtual outreach
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TABLE 1 Participating GPs and hospital clinicians
London Shrewsbury Total
Number of GPs 74 60 134
Number of practices 15 14 29
Number of consultants 
by speciality 12 8 20
Endocrinology 1 0 1
ENT 2 2 4
Gastroenterology 1 2 3
General medicine 0 2 2
Neurology 0 1 1
Orthopaedics 2 0 2
Rheumatology 2 0 2
Urology 4 1 5clinics, but generally offered appointments at the
beginning or end of their routine outpatient
clinics. Virtual outreach used PC-based technology
(Intel Business Video Conferencing version 5) and
ISDN2 links. No special fibre-optic or other
instrumentation (‘peripherals’) was available at any
site during the course of the trial.
Hypotheses
After due consideration, the following hypotheses
were selected for the trial. Compared with
standard outpatients, virtual outreach will:
  reduce offers of hospital follow-up
appointments 
  reduce numbers of medical interventions and
investigations
  reduce numbers of contacts with the healthcare
system
  have a positive impact on patient satisfaction
and enablement
  have a positive impact on patient health status.
Measuring main outcomes
The following questionnaires were used, which had
been tested in the pilot study (see Appendices 3–6).
The Short Form-12 (SF-12) and Child
Health Questionnaire (CHQ)58,59
The SF-12 is a short form of the SF-36, which was
itself a short form of a lengthier questionnaire to
measure patient health status or well-being. The
SF-36 questionnaire was developed by the Rand
Corporation and validated originally in 1980.
Further work on the internal consistency of the 
SF-36 was conducted in the UK on a randomly
selected sample of 13,042 subjects aged between
18 and 64 years. The internal consistency of the
different dimensions of the questionnaire was
found to be high. Normative data broken down by
age, gender and socio-economic status were
consistent with those of previous studies. Further
work was conducted to reduce the SF-36 to the 
SF-12. The study found that the scores calculated
from the two questionnaires were virtually
identical and indicated the same magnitude of 
ill-health and change over time.
The CHQ was developed in 1990 because of the
absence of any health outcomes for children and
adolescents other than mortality and morbidity
statistics. The CHQ has been subjected to rigorous
testing for consistency and internal reliability both
in samples of representative US children in the
general population and in clinical populations.
Little difference was found in sample subgroups
(child age, gender, parent gender, ethnicity,
education and work status). Similar results were
found in clinical samples, including subjects with
asthma, cystic fibrosis, epilepsy, juvenile
rheumatoid arthritis, and attention deficit and
hyperactivity disorder.
The Duke Severity of Illness (DUSOI)60
The DUSOI is a measure of co-morbidity or the
burden of illness during a specified week. It has
been validated both as an instrument that can be
used by a clinician at the time and for use
immediately after a patient encounter by
retrospective audit. The questionnaire is fairly
simple to complete. All medical diagnoses for
conditions in a specified week are listed. For any
condition listed, the doctor completing the form is
asked to give a score on a five-point scale for
symptoms, complications, prognosis and
treatment. A measure of co-morbidity was
necessary to control the case-mix in the control
and intervention groups.
The Ware Specific Visit Questionnaire
(SVQ)61
The SVQ was first developed in 1988 by the Rand
Corporation as part of a large-scale exercise for
evaluating patient satisfaction and medical
outcomes of medical services. The SVQ is a 14-item
questionnaire rating various aspects of a specific
visit to a medical practitioner. The items cover the
convenience of location, communication in making
an appointment waiting areas and time taken to get
an appointment or sitting in the waiting room,
together with a rating of the doctor–patient
interaction and overall satisfaction. Each item is
ranked on a five-point Likert-type scale ranging
from excellent to poor. It has been widely validated
and used in a large number of studies
The Patient Enablement Instrument
(PEI)62
The PEI was developed because it was felt that
there was a need to measure the degree to which
patients were empowered or better able to cope
with their illness following a visit to a medical
practitioner. This is in contrast to measures of
satisfaction that essentially measure whether or not
particular patient agendas are met. The
developers of the instrument have demonstrated
that the PEI can identify patients with different
types and levels of need in a way that has a strong
face validity. In addition, they showed that the
measures of consultation length (that had
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quality on a number of defined grounds) seem
interchangeable as a process measure.
The measure is based on six postconsultation
questions with good internal consistency and good
construct validity, and has been developed in such
a way that it can be scored in five ways that
measure different elements of the concept of
enablement as an outcome measure. Six questions
are involved:
“As a result of your visit to the doctor today do
you feel you are:
  able to cope with life?
  able to understand your illness?
  able to cope with your illness?
  able to keep yourself healthy?
  confident about your health?
  able to help yourself?”
The first four questions are given the choices
‘Much better’, ‘Better’, ‘Same or less’ or ‘Not
applicable’. The last two questions have the
choices ‘Much more’, ‘More’ or ‘Not applicable’.
Randomisation
GPs were encouraged to seek consent from their
patients when the decision was made to refer. As
referral letters were received, the project staff
identified all patients eligible for the trial, and
those for whom a consent form had not been
completed were sent a patient information leaflet
and consent form. The trial was deliberately kept
as inclusive as possible, but patients requiring
urgent assessment, private patients and those with
significant difficulty communicating in English
were excluded. Patients with difficulty in English
were excluded not for clinical reasons (they may
even have derived additional benefit), but because
they would not have been able to complete the
questionnaires. All other patients referred by the
participating GPs to specialists taking part were
eligible for recruitment. Shortly after the start of
the trial, the exclusion criteria were extended to
patients referred for a specific investigation (such
as a hearing test), but the small number of such
patients who had already been recruited was
retained in the final analysis. Those not eligible to
enter the trial were immediately placed into the
hospital administration. Eligible patients were
then sent a pack containing explanatory letters
and consent letters. Patients for whom consent was
obtained were randomly allocated to either the
virtual outreach or the standard outpatient
consultation arm of the trial. Computerised
randomisation in permuted blocks of sizes four
and six (arranged unpredictably) was stratified by
centre, practice and speciality. Because the
allocation had to be undertaken by research staff,
there was no opportunity for clinical staff to
influence the allocation procedure. 
Data collection
Baseline measures consisting of demographic
variables and a quality of life measure (SF-12 for
adults and CHQ for subjects aged under 16 years)
were collected on a questionnaire sent with the
appointment letter. The referring GPs completed
a DUSOI questionnaire for each patient. The
outcome measures immediately following the
index consultation included the SVQ (patient
satisfaction) and the PEI. Offer of a follow-up
outpatient appointment in the same speciality was
determined by the research nurses from review of
the content of the letter written by the hospital
specialist following the initial consultation to
which patients were randomised (the index
consultation). The research nurses extracted data
from the letters on the reasons for offering follow-
up appointments. These included inappropriate
or failed teleconsultations or decision to review the
patient when the results of investigations were
available. For the intention-to-treat (ITT) analysis,
in those cases where it was impossible to arrange a
mutually convenient time for the index
consultation, or where the GP, consultant or
patient had requested an appointment other than
the index appointment, or if there had been a
technical failure, a further appointment was
deemed to have been offered. No offer of a follow-
up appointment was deemed to have been made
to patients who had moved away, repeatedly did
not attend the index consultation, were admitted
to hospital, stated that they had got better and no
longer wished to be seen, or had died. 
In the early phases of the trial, hospital specialists
were requested to complete a data form of the
consultations, recording information relating to
diagnosis, investigations ordered, treatments and
interventions prescribed or planned, and any
referral to another specialist. In the virtual
outreach arm of the trial, they were also asked to
rate appropriateness of the consultation using a
Likert scale. However, as it proved impossible to
achieve satisfactory rates of completion of these
questionnaires by the specialists, the form was
abandoned in the early stages of the trial. 
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where relevant, the CHQ. In addition, information
was collected from general practice and hospital
records, for 6 months following the index
consultation, about investigations, interventions
and treatments, consultations with primary care
professionals, and inpatient and outpatient
consultations. 
To identify resource use that was specific to the
randomised interventions, criteria for defining
‘attributable items’ were agreed by the research
team, following independent data extraction from
a subsample of records by two nurse researchers.
Those where there was agreement that they were
specific to the speciality to which the patient had
been referred (e.g. gastroscopy for patients
referred to a gastroenterologist) were designated
as attributable to the index consultation for the
final analysis, as were all of the non-specific items
carried out within 4 weeks of the consultation.
Analyses were carried out on both attributable and
total data. Criteria for attribution of tests and
investigations are described more fully below
(Economic evaluation methods; Tests,
investigations, procedures and contacts with
healthcare services over 6 months).
Because of the practical difficulties in obtaining
prescription data from paper records, prescription
data were obtained only from those practices using
computerised prescribing systems that readily
facilitated data capture in electronic form (12 in
London and 11 in Shrewsbury). Criteria for
attribution of prescriptions are described more
fully below (Economic evaluation methods;
Prescription costs).
Statistical methods
The sample size, based on the study by Vierhout
and colleagues35 was chosen to detect a reduction
of 20% (from 60% to 40%) in follow-up outpatient
appointments offered following the index
consultation (the primary outcome) between the
randomised groups, both overall and separately for
each of the five predefined speciality groups (ENT,
orthopaedics, urology, gastroenterology and other
medical specialities) with 90% power and 5%
significance. The study required 250 patients in
each speciality, and allowing for imbalance in
anticipated numbers between specialities and a
potential 30% of missing outcome data, the study
required a total of 1950 patients.63 The statistical
analysis followed a prespecified plan, considering
the groups as randomised. Primary and secondary
outcomes were specified a priori. The p-values
reported are not formally adjusted for multiple
comparisons. Thus, among the secondary
outcomes, some apparently significant differences
may have arisen by chance. Adjustment for
baseline characteristics (see footnote to Table 6, 
p. 23) was by logistic regression for binary
outcomes and normal errors regression for
quantitative outcomes. Tests of interaction were
used to assess whether the effect of virtual outreach
varied by speciality or site (London or Shrewsbury).
Health service data were compared using means,64
as were Ware satisfaction and enablement scores.
The latter two analyses were checked, respectively,
using proportional odds regression and logistic
regression of the proportion of patients with non-
zero scores.65 The analyses on offer of follow-up
were calculated both on the basis of ITT and ‘per
protocol’, restricted to those who received the
intervention as randomised and those for whom
there was a consultant letter. The ITT analysis is
presented as the primary results. In the case of
satisfaction and patient enablement, analyses were
performed per protocol rather than on an ITT
basis, because the responses to questions on these
issues were related to the patients’ experience at
the index consultation. A higher proportion of
those in the virtual outreach group did not receive
the index consultation, and therefore missing
outcome data relating to the index consultation
were generally more frequent in this group. The
extent of these and other missing data also varied
somewhat by site and speciality, and by patient age
and gender. However, adjustment for these
characteristics did not change the interpretation of
any of the results, suggesting that any biases caused
by missing data are small. Various other sensitivity
analyses were performed, for example excluding
patients with apparently incomplete GP or hospital
notes from the analyses, without changing the
interpretation of the results. In the case of outcome
data extracted from medical records, the
proportion of missing data was very low and did
not differ between the groups. 
Economic evaluation methods
The hypotheses of the economic evaluation were
that, compared with conventional outpatients,
virtual outreach will:
  incur no increased costs to the NHS 
  reduce the costs incurred by patients attending
outpatient appointments
  reduce the time taken off work (positive impact
on productivity).
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The economic evaluation focused on actual
resources used and a cost for each patient was
derived for the index consultation and 6-month
follow-up period. 
Index consultation
The index consultations, that is, the consultations
to which patients were randomised, were costed
using an ‘ingredients’-based approach. The
important elements included capital and overhead
costs, professional time and telephone line costs.
Non-participant observation was used to estimate
time spent from a small sample of consultations
selected opportunistically because of the logistical
problems of scheduling observations and the
substantial research time involved. Joint
teleconsultations were observed at the GP practice
and the hospital clinic to estimate the respective
time input of the two physicians. More
consultations were observed at the consultant end,
because the location was more accessible and
because consultants often undertook several trial
consultations in a single clinic session. Of the 35
standard outpatient appointments observed, 26
were at Shrewsbury and nine were at London. In
London 25 teleconsultations were observed,
although the patient did not attend in two cases.
Of these, nine were observed at the GP practice
and 16 in a hospital setting. Seven consultants,
representing urology, endocrinology,
rheumatology, ENT, gastroenterology and
orthopaedics, were observed in the hospital setting
and seven GPs were observed in six different
practices. In Shrewsbury six teleconsultations were
observed at both GP practice and hospital. In
total, four consultants were observed, covering
gastroenterology, respiratory medicine and ENT
specialities. In all, nine conventional outpatient
appointments were observed in ENT and
gastroenterology in London. In Shrewsbury 26
conventional appointments in total were observed
for specialists in gastroenterology, ENT and
respiratory medicine. Sensitivity analysis was used
to explore the implications of errors resulting
from these estimates.
The costs of training clinicians in the use of the
videoconferencing equipment and some
administrative functions undertaken by the research
team have not been included in the analysis of
consultation costs. These administration costs were
considered to be largely an artefact of the trial
design and of little relevance to service delivery. It
was assumed that the relatively small training costs
could be absorbed within ongoing training costs
that are included within the calculation of the cost
of clinician time. The complete record for the
timing of index consultations is given in Table 2.
Table 3 summarises the ingredients costs used for
each consultation type. 
The cost calculation for clinician time was based
on data compiled by Netten and Curtis.56 The cost
of a minute of GP’s time was £1.96 and various
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TABLE 2 Timings of trial appointments
Duration (minutes)
n Mean (SD) Range  95% CI
Joint teleconsultation
Consultation duration 31 10.5 (5.1) 3–22 8.6 to 12.4
Total GP time 14 26  (10.1) 9–45 20.2 to 31.8
Total consultant time 22 19.9 (8.3) 8–37 16.2 to 23.6
Conventional outpatient appointments
Consultation duration 35 9.3 (5.2) 3–25 7.5 to 11.0
Total consultant time 35 11.8 (6.2) 5–27 9.7 to 13.9
CI, confidence interval.
TABLE 3 Costs of virtual outreach index appointments
Teleconsultation Conventional
Labour
GP £50.96
Consultant £57.71 £34.22
Consumables
Call charges £0.71
Capital
Videoconferencing £23.52
units
Trolleys £0.12
Cabinets £0.10
Overhead
ISDN rental £31.50
Software installation £12.37
ISDN installation £15.19
Marginal cost of  £109.38 £34.22
consultation
Average cost of  £192.17 £34.22
consultationpractice overheads and training costs are
embodied within this figure. The cost of a minute
of consultant’s time was £2.90. Overheads,
including secretarial support and training costs,
are included in Netten and Curtis’s figure (£1.82),
but nursing and clinic costs associated with an
appointment are not. To ensure comparability
between GP and consultant costings, estimates of
nursing and clinic costs provided by the Royal
Free Hospital Trust were added to the Netten’s
figure for the cost of consultant’s time. 
Call charges were incurred according to the
duration of the triadic consultation. Additional
capital and overhead costs associated with virtual
outreach for the purchase of equipment and the
installation and rental of ISDN telephone lines
were included. These costs that do not vary with
output, unlike those for line charges, are
nevertheless essential to the provision of the
service. The cost per consultation was the total
fixed costs divided by the number of consultations.
The fixed cost component of a consultation is thus
an artefact of the number of consultations in the
trial. To take this into account, the costs for a
single consultation are reported with and without
the fixed cost component. The capital costs of the
videoconferencing equipment and accessories were
annuitised over the expected lifetime of the asset
using an interest rate of 6%.66 The lifetime was
assumed to be 5 years for the videoconferencing
equipment and 20 years for cabinets and trolleys.
A total of 889 teleconsultations took place in the
Virtual Outreach Project in 21 months. This works
out at approximately 500 teleconsultations per
year. Therefore, the equivalent annual cost was
divided by 500 to derive a capital cost per
consultation. Normal practice and hospital
overhead costs are incorporated into the labour
costs of GPs and consultants. However, virtual
outreach consultations introduce new overheads,
such as ISDN line rental and software installation,
and these were assigned to individual consultations
by dividing the total cost by the number of
teleconsultations (n = 889). In total, 225 patients
did not attend their index consultation, but as
most of them gave notice of this it was assumed
that the NHS incurred no costs for these cases.
The effects of relaxing this assumption were
investigated using sensitivity analysis.
Prescription costs
Prescription issues and costs were collected
electronically from the computerised record
systems of GP practices using EMIS version 5®
software. Appendix 7 provides a detailed
description of how these data were collected and
organised. As many of the prescriptions issued did
not relate to the index consultation, this was
adjusted for in the following way. Prescription data
were collected for patients in the 6 months either
side of the index consultation. (A reference date of
1 month after randomisation was used in the
event that the patient did not attend their index
appointment.) A prescription issued after the
index consultation was deemed to be attributable
to the index consultation if the patient did not
receive the same named prescription in the 6
months before the index consultation. The
attribution was undertaken by a non-clinician and,
as subjective assessment was not required, the
method was thought to be robust and unbiased.
The exercise was validated with a clinician in one
practice and agreement was reached on 182 out of
184 items. Clinical methods of attribution were
not feasible within the timescale and resources of
the project. With the exception of one practice in
London, prescription data were not analysed from
those GP practices using non-EMIS version 5®
computerised systems. This was because the data
could not be exported electronically in a timely
and useful fashion. The GP practice with the
greatest number of trial patients in the London
arm of the trial used Torex Premiere®, and data
from this practice were collected electronically and
included in the analysis. The omission of a
number of practices from the prescription analysis
is unfortunate, but should not introduce any
systematic biases as the patients in these practices
were evenly distributed across the two arms of the
trial (153 in the virtual outreach group and 150 in
the standard outpatient group). 
Tests, investigations, procedures and contacts
with healthcare services over 6 months
Research nurses collected data on the patient’s use
of NHS resources in the 6 months after the index
consultation from hospital and GP records. A
standard form was devised as the data collection
instrument and a coding system was agreed for
recording items of resource use. Resource items
were grouped into the following categories:
  visits to the GP practice
– visits to GP
– visits to nurse
– visits to other clinical practice staff
– home visits
– other patient contacts with the practice
  contacts between hospital consultant and GP
  X-ray and radiological investigations
  blood tests and laboratory investigations
  other tests and investigations
  visits to the outpatients department
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  attendances at the accident and emergency
department
  attendances for day surgery and other inpatient
procedures
  any other hospital visits
  any other hospital contacts.
Each resource item was given a code and a unit
cost was assigned to it. With the exception of visits
to the GP practice, the unit costs were obtained
from 1999/00 data supplied by the Royal Free
Hampstead NHS Trust, the Royal Shrewsbury
Hospital NHS Trust and NHS Reference Costs
2000.67 Unit costs for visits to GP were derived
from Netten and Curtis.56
Attribution to the index consultation
As with the prescription data, much of the 6-
month resource use was unrelated to the condition
that led to the patient’s recruitment into the trial.
To reduce this noise, criteria were developed for
identifying items of resource use that could be
deemed to be attributable to the index
consultation speciality, for example, a gastroscopy
for a patient referred to a gastroenterologist.
Other items such as GP visits, blood tests and
laboratory investigations were classified as
attributable if they occurred within 4 weeks of the
index consultation (or from a reference date set 
1 month after randomisation if the patient did not
attend their index consultation). Although this was
felt to be a robust method, it did not determine
‘attribution’ to the index consultation in a clinical
sense. In selecting these criteria a trade-off was
made between sensitivity and specificity. By
excluding non-speciality specific tests, some
resource items were excluded that were genuinely
attributable to the index consultation (false
negatives). However, had this category been
included, many resource items not attributable to
the index consultation would have been counted
as attributable (false positives). Similarly, reducing
the time cut-off for attributable items increased
specificity at the expense of sensitivity. In the
Shrewsbury arm of the trial the research nurses
also categorised attributable resource items using
their clinical judgement. They coded each
resource item as attributable, not attributable and
uncertain. An inter-rater reliability exercise was
undertaken which showed that there were no
material differences between the assessments of
the different research nurses. 
Patient costs and impact on productivity
Data on the costs incurred by patients were
collected from a postal questionnaire. Patients
were asked to record any travel costs incurred by
themselves (or anyone accompanying them) in
attending their index consultation, and time
taken, including travel, to attend the index
consultation. They were also asked to provide
information about the impact on their work and
that of anyone accompanying them. If there was
any work lost, questions were asked about whether
pay was lost or whether they or anyone
accompanying them had had to take annual leave.
Questions were also asked about associated
childcare costs. Productivity losses were estimated
using data from the New Earnings Survey68 and
from responses to questions about whether either
the patient or companion had to take time 
off work. 
Comparison with physical outreach
It had originally been intended to include an
economic comparison of virtual outreach with
physical outreach clinics. This comparison was to
have been undertaken using a data set on physical
outreach clinics generated by Bowling and Bond.33
However, it became apparent before the trial
commenced that there were too many differences
between the two data sets for the comparative
analysis to be undertaken. It would not have been
feasible within the available financial resource
allocation to undertake additional data collection
on physical outreach clinics, and it was therefore
decided to abandon this comparison. 
Economic and statistical methods
Economic evaluation may take various forms.
Cost–benefit analysis estimates the costs and
benefits to all those affected over the duration of
the project in money terms, to allow for
comparisons with investments in other sectors of
the economy. If the effects can be measured as a
single outcome measure, a cost-effectiveness study
may be used. Many projects have multiple
dimensional outcomes and attempt to aggregate
these disparate outcomes using an index to
measure the quality-adjusted life-years (QALYs).
Some studies do not attempt to aggregate
outcomes in this way, but estimate costs and
delineate as clearly as possible the consequences of
the intervention. Methodologically, one of the key
problems with such cost–benefit assessment studies
is the requirement to make general conclusions
based on the monetary values assigned to
outcomes. Unlike the QALY approach, this does
not really facilitate comparisons across different
healthcare programmes. For example, the
willingness to pay (WTP) values from one study
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be compared with the WTP values of another
study that valued a different programme with a
different set of characteristics. 
Decision-analytic modelling is an approach to
decision-making under conditions of uncertainty
and is widely used in the economic evaluation of
healthcare to assess the consequences of different
treatment strategies. For each strategy, the
important patient pathways are modelled by
assigning probabilities to different events and
valuing the outcomes and costs associated with
each end-point. 
A simple decision-analysis model that may have
been adopted for the Virtual Outreach Project is
shown in Figure 1. The ‘treatment’ arms of the
decision tree are essentially a catch-all for the
myriad different treatment pathways that patients
experience. These pathways vary according to
speciality and underlying condition, with marked
differences in the probabilities of different events
and outcomes. 
Such decision-analytic models are sometimes used
to complement the data from randomised trials,
where a longer time horizon than that provided by
the trial is needed to evaluate fully the costs and
outcomes, for example. One hypothesis of the
Virtual Outreach Project was that teleconsultation
would reduce downstream costs to the NHS as a
result of improved patient management, although
it was acknowledged that not all of these savings
may be captured within the 6-month follow-up
period.
However, although theoretically it would have
been useful to model beyond the 6-month period
this was not undertaken because of the practical
difficulties involved. The parameters for such
models are normally estimated from the literature
or expert opinion. In this case, the study would be
modelling the counterfactual: how would pathways
differ in resource use and health outcomes if
patients received an innovative virtual outreach
consultation as opposed to a conventional one?
Although this study was able to provide evidence
for costs and outcomes for the 6-month period
immediately after the index consultation, anything
beyond this would be pure speculation. Another
problem concerned the nature of the treatment
arms. Such a generic category would not be useful
for extrapolations beyond the 6-month period.
Any long-term data on resource use and health
outcomes would depend more on the condition
than the mode of specialist consultation, although
this may moderate both. However, the Virtual
Outreach Project included patients with a range of
different conditions and many had co-morbidities.
Even if a specific condition were identified within
the trial, it is likely that the sample sizes would be
too small to enable meaningful conclusions to be
drawn about the probabilities of outcomes and
costs for such conditions, even for the 6-month
follow-up period covered by the trial. More
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FIGURE 1 Decision-analysis modelgenerally, the noise problem encountered in the
trial in relation to resource use would be
compounded by longer follow-up, and again this
would be difficult to address within a decision-
analytic model. 
Taking all of these factors into account, a
cost–consequence approach was adopted for this
study that involved reporting an array of output
measures alongside costs. The perspective of the
evaluation embraced the perspective of the patient
in addition to the NHS, but it fell short of a
societal approach involved in a full cost–benefit
study. The statistical analysis for the economic
evaluation followed a prespecified plan. Costings
were based on actual not prescribed resource use,
as this reflects ‘real’ practice. For 21 patients the 
6-month resource use data were missing. For these
patients, resource use was imputed using the mean
values for patients with data by site and
consultation type. For example, the values
imputed for a London patient in the standard
outpatient group with missing data would be the
mean value obtained for London patients in the
standard outpatient group. For the 353 patients
with missing prescription data, mean values were
imputed according to the same method. Some
data were missing from self-completed patient
questionnaires, and again values were imputed.
For patients who indicated that they had incurred
costs for travel by private car but had not stated
the amount, the distance of their return trip from
their home to appointment location was calculated
using http://www.multimap.com, and a cost
imputed based on an average cost of travel of 20
pence per mile.69 Where it was not clear whether
the patient had incurred a cost or not, the value
imputed was based on the mean of all patients
with complete data, regardless of whether they
incurred a cost or not. 
Resource use and cost data were compared using
means, with pooled variance t-tests used to test for
differences in patient and NHS costs between the
two arms of the trial. Other techniques to increase
the power of the estimates such as bootstrapping
were not required as sample sizes were large.70
Adjusted analyses using multiple regression models
were used to improve the precision of the estimated
treatment effect, or to allow for imbalances in
baseline characteristics. Adjusted analyses using
multiple regression models were used to improve
the precision of the estimated treatment effect or
to allow imbalances in baseline characteristics: site,
speciality, age, gender and DUSOI. In addition,
tests of interaction were used to investigate site
and speciality effects on resource use and cost. 
In economic evaluation, sensitivity analysis is often
used to explore the robustness of results in the
face of uncertainty about data values. In this trial,
the key uncertainty centred on the parameter
values used to derive the index consultation costs.
Therefore, one-way sensitivity analysis was
undertaken on a range of parameters associated
with the index consultation, namely
teleconsultation duration, conventional
consultation duration, total GP time, total
consultant time, the cost of videoconferencing
equipment, the lifespan of videoconferencing
equipment, the cost of non-attendance and the
number of consultations per annum. The
following parameters were varied in the sensitivity
analysis. 
  Consultant time, conventional appointment: if
conventional outpatients appointments had
been typically longer than in the observed
sample, then the cost difference would have
been less than those based on the present
observations. The observed time was 
11.8 minutes and this set the benchmark for the
bottom of the range (rounded down to 
11 minutes). Data from the Royal Free Hospital
suggested that a consultation time of 
19.1 minutes was used as the basis for
calculating the costing of outpatients. This
value was therefore used as the basis for the
upper range in the sensitivity analysis.
  Teleconsultation duration: this refers to 
the actual length of the joint teleconsultation. 
If these had been typically of shorter 
duration than actually observed, then cost
difference between the consultation types 
would have been reduced. The ranges used
reflect the ranges observed in the non-
participant observation of virtual outreach
consultations.
  Consultant time, teleconsultation: if the
observations had overstated the typical
consultant input, then the cost difference would
have been exaggerated. The ranges were based
on the observed joint teleconsultation duration
plus the ranges of other consultant input
observed in joint teleconsultations, such as
administration and set-up. 
  GP time, teleconsultation: the same reasoning
and method were used as for consultant
teleconsultation time.
  Videoconferencing equipment: it was difficult to
gauge uncertainty with regard to cost of
equipment, as increasing technology tends to
increase cost, but the cost of any given
technology tends to fall rapidly. Therefore, a
wide range was used. 
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18  Videoconferencing equipment lifespan: this was
included because it impinges on capital costs.
The ranges used were necessarily arbitrary.
  Joint teleconsultations per annum: this factor
was included because it has been noted that
volume effects can affect cost-effectiveness. 
For the best case sensitivity analysis the
parameters for a number of variables are varied
simultaneously. Time values for virtual outreach
are based on the lower interquartile range of
observations. Consultant input into conventional
outpatients is estimated from Royal Free Hospital
data. The values used for the number of
consultations and cost of equipment are indeed
arbitrary (although both in favour of virtual
outreach compared with the baseline), although it
is difficult to envisage how they could be
determined scientifically, without considerable
research effort. Such effort is probably not
worthwhile given that their effect on overall costs
of a virtual outreach consultation is fairly modest
at these levels. Overall, as acknowledged in the
report, the best case scenario is optimistic, but
illustrates what conditions would be necessary to
make virtual outreach consultations a more viable
proposition.
In addition, a multiway sensitivity analysis was
used to assess a best case scenario for joint
teleconsultations. This involved making optimistic
assumptions about parameter values relating to
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All apparently eligible referrals from GPs
3170
Eligible for trial and randomised
2094
Failed to provide consent or
actively refused consent
1040 Found to be ineligible
36
Standard outpatients
1043
Virtual outreach
1051
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FIGURE 2 CONSORT diagram: recruitment and completion of the trial. a Patients on whom data were extracted from the consultant’s
letter or from other sources. the costs of a virtual outreach appointment and
pessimistic assumptions about the duration of a
conventional appointment.
Recruitment of patients
For the duration of the recruitment phase of the
trial (January 2000 to December 2000), staff in the
research offices at each site reviewed all the
referral letters sent by the participating GPs to
identify eligible patients. 
Randomisation
Of 3170 apparently eligible patients considered
for the trial, 2094 were randomised (Figure 2). In
total, 1040 patients were eligible for the trial but,
for a variety of reasons, did not provide consent
(Table 4).
Those that were not randomised, mainly because
consent was not obtained, included a greater
proportion of younger London patients, but were
similar in other ways to the trial participants.
Thirty-six patients were subsequently found to be
ineligible (most of them because of referral to a
consultant who withdrew from the study before
seeing any patients) and were excluded from the
trial. Different specialities were eligible in London
Methods
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TABLE 4 Characteristics of those 1040 patients eligible for the
trial but who did not provide consent
n (%)
Site
London 797 (77)
Shrewsbury 243 (23)
Speciality
Orthopaedics 174 (17)
Urology 194 (19)
ENT 272 (26)
Gastroenterology 226 (22)
Endocrinology 60 (6)
Rheumatology 57 (5)
General medicine 36 (3)
Neurology 21 (2)
Gender
Male 508 (49)
Female 532 (51)
Age (years)a
Mean (SD) 44 (21)
a Age at date of referral letter (missing for ten patients).
TABLE 5 Baseline comparability of randomised groups
Virtual outreach Standard
Number randomised 1051 1043
London centre 616 616
Speciality
Orthopaedics 185 (30%) 190 (31%)
Urology 117 (19%) 113 (18%)
ENT 109 (18%) 111 (18%)
Gastroenterology 117 (19%) 121 (20%)
Other medical specialities 88 (14%) 81 (13%)
Shrewsbury centre 435 427
Speciality
Urology 29 (7%) 35 (8%)
ENT 186 (43%) 179 (42%)
Gastroenterology 98 (22%) 95 (22%)
Other medical specialities 122 (28%) 118 (28%)
Both centres
Male 509 (48%) 508 (49%)
Age at randomisation (years), mean (SD) 48.4 (20.8) 48.1 (20.7)
White ethnic groupa 848 (90%) 835 (88%)
DUSOI (overall score)b, mean (SD) 48.2 (17.5) 49.9 (18.2)
SF-12 Physical scorec, mean (SD) 47.1 (12.2) 47.5 (12.3)
SF-12 Mental scorec, mean (SD) 42.1 (11.6) 41.2 (11.8)
a Based on 1889 patients.
b Based on 1774 patients. Scores range from 0 (low severity) to 100 (high severity).
c Based on 1569 adults (>16 years). CHQ scores for those less than 16 years were also balanced between groups. and Shrewsbury, but these and other baseline
characteristics, including marital and employment
status and measures of socio-economic status, were
well balanced between the two randomised groups
(Table 5). 
For 139 patients, it was impossible to arrange a
mutually convenient time for the index
consultation, or the GP, consultant or patient
requested an appointment other than the index
appointment. A technical failure occurred with
eight patients, and 78 patients moved away,
repeatedly did not attend the index consultation,
were admitted to hospital, stated that they had got
better and no longer wished to be seen, or were
found to have died. Following the index
consultation, 15 patients withdrew consent 
and in 140 cases no consultant letter was 
available. These latter cases were evenly
distributed between the virtual outreach and
standard groups, and were therefore not included
in the ITT analysis. 
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sing the ITT analysis described in Chapter 2,
it was calculated that 52% of patients in the
virtual outreach group were offered a follow-up
appointment, compared with 41% in the standard
outpatient group (Table 6). 
This difference was hardly changed by adjustment
for baseline characteristics. Differences in the
frequency of offer of follow-up between
randomised groups were observed in the two sites,
and across different specialities (tests of interaction
p = 0.009 and p < 0.001, respectively). The
difference in frequency of offer of follow-up
between the two groups was substantially higher in
Shrewsbury than in London. It was also higher in
ENT and orthopaedics than in urology,
gastroenterology or the other medical specialities
(Table 6). The tests of interaction remained
statistically significant when both site and
speciality were considered together, and when
adjustment was made for baseline characteristics.
The absolute differences in the proportions of
offered follow-up appointments, calculated on the
basis of ITT, are shown in Figure 3. When
comparisons were made per protocol (i.e.
including only those patients who actually received
the trial intervention and for whom there was a
letter from the specialist), the overall proportion
of patients receiving an offer of follow-up was 46%
in the virtual outreach group and 42% in the
standard outpatient group (odds ratio 1.19, 
95% CI 0.99 to 1.44), but significant heterogeneity
remained for both site and speciality (p = 0.001
and p < 0.001, respectively). Information on tests
and investigations, and the numbers of contacts
with healthcare services over 6 months is
summarised in Table 7. 
On average, there were significantly fewer tests
and investigations in the virtual outreach group.
Other contacts with healthcare services did not
differ between the randomised groups. However,
of those 157 patients in the virtual outreach group
for whom the consultant letter indicated an
inappropriate or a failed joint teleconsultation,
126 (80%) had an attributable outpatient visit in
the 6-month follow-up period, compared with
341/876 (39%) of the remaining participants
randomised to virtual outreach (p < 0.001). Tests
of interaction showed evidence of differences in
effects by speciality for number of tests and
investigations (p = 0.01) and outpatient visits 
(p = 0.007). In particular, the effect of virtual
outreach in decreasing the number of tests and
investigations was more marked in
gastroenterology. However, virtual outreach
Health Technology Assessment 2004; Vol. 8: No. 50
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TABLE 6 Offer of follow-up appointment (ITT analysis)
Virtual outreach Standard Odds ratio p-Value
(95% CI)
Number of patients n = 971 n = 968
Overall: Unadjusted 502 (52%) 400 (41%) 1.52 (1.27 to 1.82) p < 0.001
Adjusteda 1.52 (1.26 to 1.81)
Adjustedb 1.53 (1.27 to 1.83)
By site: Unadjusted Interaction p = 0.009
London 281 (50%) 254 (45%) 1.25 (0.99 to 1.57)
Shrewsbury 221 (54%) 146 (37%) 2.02 (1.53 to 2.68)
By speciality: Unadjusted Interaction p < 0.001
Orthopaedics 89 (54%) 59 (34%) 2.24 (1.45 to 3.48)
Urology 59 (46%) 49 (35%) 1.59 (0.97 to 2.60)
ENT 178 (63%) 94 (36%) 3.13 (2.20 to 4.43)
Gastroenterology 88 (44%) 99 (49%) 0.80 (0.54 to 1.18)
Other specialities 88 (45%) 99 (52%) 0.76 (0.51 to 1.14)
a Adjusted for site, gender, age at randomisation and speciality. 
b Adjusted for site, gender, age at randomisation, speciality and DUSOI overall score. Results from missing indicator method
(UK 700 Group71).Main trial results
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TABLE 7 Tests, investigations and contacts with healthcare services over 6 months
Virtual outreach Standard Difference p-Value
Mean Mean (95% CI)
Patients with resource use data n = 1033 n = 1025
Number of tests and investigations 
(unadjusted) 3.22 4.01 –0.79 (–1.21 to –0.37) p <0 .001
By speciality (unadjusted): Interaction p = 0.09
Orthopaedics 2.54 2.35 0.19 (–0.77 to 1.15)
Urology 3.43 4.40 –0.97 (–2.04 to 0.11)
ENT 1.76 2.30 –0.54 (–1.30 to 0.22)
Gastroenterology 4.63 6.68 –2.04 (–2.94 to –1.16)
Other specialities 4.27 4.91 –0.64 (–1.55 to 0.27)
Number of outpatient visits  1.32 1.28 0.04 (–0.10 to 0.18) p = 0.57
(unadjusted)
By speciality (unadjusted): Interaction p = 0.007
Orthopaedics 1.55 1.14 0.41 (0.09 to 0.73)
Urology 1.45 1.69 –0.24 (–0.61 to 0.12)
ENT 1.20 1.00 0.20 (–0.05 to 0.46)
Gastroenterology 1.13 1.43 –0.30 (–0.60 to –0.006)
Other specialities 1.38 1.34 0.04 (–0.27 to 0.35)
Total number of contacts with general  3.47 3.27 0.20 (–0.11 to 0.50) p = 0.21
practicea
Number of accident and emergency visits 0.06 0.06 0.002 (–0.02 to 0.03) p = 0.85
Number of inpatient stays 0.11 0.13 –0.02 (–0.06 to 0.01) P = 0.15
Number of day surgery and inpatient  0.11 0.12 –0.01 (–0.04 to 0.02) p = 0.52
visit
Patients with prescription data 852 859
Number of prescriptions  8.72 8.15 0.57 (–0.64 to 1.78) p = 0.36
a GP notes for two patients in the standard group were missing.
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FIGURE 3 Differences in the percentage of patients offered a follow-up hospital appointment (virtual outreach – standard) with 
95% CIsincreased the number of actual outpatient visits in
orthopaedics. Adjustments for baseline
characteristics did not change any of these results.
The conclusions were the same when restricted to
those items regarded as attributable to the index
consultation. For example, the difference between
the randomised groups in the number of tests and
investigations was still around 0.8 per patient, now
based on averages of 1.16 and 1.93 in the two
groups.
Patient satisfaction was significantly greater after a
virtual outreach consultation than after a standard
outpatient consultation (Table 8 and Figure 4).
The difference between the randomised groups in
overall patient satisfaction was also evident in all
13 individual items in the SVQ, for example
convenience of location, waiting area, time of
appointment, time in consultation, manner of
reception staff and attention to what the patient
had to say (Table 9).
Patient enablement after the consultation, 
and the physical and psychological scores of the
SF-12 at 6 months, did not differ between the
randomised groups (Table 8). Scores on the CHQ
(used instead of the SF-12 for adults, for the 170
patients under 16 years) also showed no 
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TABLE 8 Patient outcomes
Virtual outreach Standard Difference p-Value
Mean (SD) Mean (SD) (95% CI)
Satisfactiona (number of patients) n = 767 n = 817
3.97 (0.99) 3.64 (1.06) 0.33 (0.23 to 0.43) p < 0.001
Enablementb (number of patients) n = 752 n = 805
2.5 (3.2) 2.4 (3.1) 0.07 (–0.24 to 0.38) p = 0.67
SF-12 (number of adult patients) n = 648 n = 700
Physical score 43.1 (12.0) 42.7 (12.2) 0.34 (–0.96 to 1.64) p = 0.61
Mental score 47.5 (11.8) 48.1 (11.9) –0.51 (–1.78 to 0.76) p = 0.43
a Overall satisfaction scored 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.
b PEI total score calculated from six questionnaire items as advised by Howie and colleagues.62 High scores indicate
improved enablement.
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FIGURE 4 Responses to overall patient satisfaction by randomised groupdifference between randomised groups, either
considered separately or combined with the 
SF-12 results using standardised differences.72
There was no evidence of interactions by site or
speciality for satisfaction, enablement or SF-12 (all
p > 0.2), and adjustment for baseline
characteristics (including baseline SF-12) did not
change the results. 
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TABLE 9 SVQ: descriptive results for 13 patient satisfaction itemsa
Virtual outreach Standard
Mean (SD) Mean (SD)
How long you waited for appointment (n = 1588) 3.51 (1.08) 3.32 (1.13)
Convenience of location (n = 1579) 4.25 (0.85) 3.53 (1.05)
Getting through by phone (n = 710) 3.65 (1.15) 3.30 (1.17)
Length of time waiting (n = 1583) 3.83 (1.05) 3.29 (1.25)
Time in consultation (n = 1573) 3.84 (1.02) 3.56 (1.13)
Ease of making/changing appointment (n = 467) 3.56 (1.22) 3.38 (1.20)
Convenience of time of appointment (n = 1582) 3.86 (0.95) 3.52 (0.99)
Personal manner of the reception staff (n = 1587) 4.18 (0.89) 3.82 (1.06)
Waiting area (n = 1587) 3.96 (0.91) 3.14 (1.10)
Attention to what you had to say (n = 1585) 4.05 (0.92) 3.62 (1.08)
Explanation of what was done to you (n = 1560) 3.90 (0.99) 3.62 (1.13)
Technical skills of doctor (n = 1564) 4.11 (0.92) 3.94 (1.02)
Personal manner of doctor (n = 1587) 4.30 (0.83) 3.97 (1.07)
a All items scored 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.Costs to the NHS
Index consultation 
In total, 66 consultations were observed. The
timings for the virtual outreach and standard
outpatient consultations observed are shown in
Table 2. The costs for the virtual outreach and
standard outpatient consultations calculated from
these observations are given in Table 3. 
A total of 225 patients did not attend their index
consultation, 155 in the virtual outreach group
and 70 in the standard outpatient group.
Assuming that the NHS did not incur any costs as
a result of the non-attendance of patients in the
trial, the mean cost of the patient’s index
consultation was £164 in virtual outreach and £32
in standard outpatients, an increased cost of £132
in the virtual outreach project. 
Costs of tests, investigations and
contacts with healthcare services over 
6 months
The use of NHS resources in the 6 months after
the index consultation was divided into use of
resources associated with primary care visits and
contacts, secondary care visits and contacts, and
tests and procedures. The mean costs per patient
for these subcategories are shown in Table 10. 
In none of these categories was there a significant
difference between the two arms of the trial, and
this remained the case after adjusting for baseline
characteristics. As reported elsewhere,63 the number
of tests was larger in the standard outpatients
group, and this is reflected in the higher mean costs
for tests and procedures. However, the cost impact
of this excess is modified by the fact that the
greatest difference occurred in the subcategory of
laboratory investigations, which are generally
cheaper than less routine tests and investigations. 
The breakdown of costs for tests and procedures
by speciality is shown in Table 14. The attribution
exercises undertaken by the research nurses in the
Shrewsbury arm of the trial gave similar results to
those reported in Table 11 for secondary care visits
and contacts, and tests and procedures. Costs were
higher in the standard outpatient group, with the
mean difference between the groups in costs being
£7.10 (95% CI –£25 to £39, p = 0.67) and £33.96
(95% CI –£8 to £75, p = 0.11), respectively.
However, this exercise found that the costs of
primary care contacts and visits were significantly
greater in the virtual outreach group. The mean
difference in costs was £8.05 (95% CI £1.59 to
£14.51, p = 0.01). 
Prescription costs
The mean number and cost of total prescriptions
issued per patient in the 6 months after the index
consultation are shown in Table 10. There were no
significant differences between the costs in the two
arms of the trial overall, or by site or speciality.
Basing the analysis on the subset of attributable
prescriptions also failed to show any significant
differences. 
Total NHS costs
The total costs to the NHS were estimated as 
£723 per patient in the virtual outreach group and
£632 per patient in the standard outpatient group,
a mean difference of £91 (95% CI £2 to £180, 
p = 0.03) (Table 11). Differences in mean total
NHS costs between virtual outreach and standard
outpatient groups by site and speciality are shown
in Figure 5. 
Tests of interaction did not demonstrate
heterogeneity by site or speciality (Table 12),
although the difference in cost between the virtual
outreach and standard outpatient group was not
statistically significant in Shrewsbury or in any
speciality other than orthopaedics. The use of
bootstrapping to allow for the skewed distribution
of costs gave very similar results; this was as
expected because the sample size was large.
When the analysis was restricted to attributable
resource use (Table 13), costs to the NHS were
£393 per patient in the virtual outreach group and
£293 per patient in the standard outpatient group.
The mean difference of £100 is similar to that
obtained using total resource use, but is now highly
significant (95% CI £65 to £134, p < 0.001).
Adjusting for baseline characteristics did not affect
these results. Tests of interaction suggested that
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TABLE 10 Use of resources during the 6-month follow-up period, with unit costs
Item Use of resources Unit cost or  Source of unit 
Mean (SD) range  cost
Virtual outreach Standard
Number of patients n = 1033 n = 1025
Primary care services
GP  2.40 (2.59) 2.27 (2.39) £25.00 Netten and Curtis56
Practice nurse  0.73 (1.49) 0.63 (1.32) £9.00 Netten and Curtis56
Other clinical staff 0.04 (0.38) 0.06 (0.43) £9.00 Netten and Curtis56
Home visits 0.05 (0.30) 0.07 (0.44) £45.00 Netten and Curtis56
Other contacts  0.25 (0.68) 0.24 (0.74) £6–19.60 Netten and Curtis56
GP estimate
Contacts between hospital and GP  0.24 (0.62)  0.16 (0.49)  £18.90 Netten and Curtis56
GP estimate
Tests, investigations and procedures
X-ray and radiological investigations 0.48 (0.95) 0.54 (0.92) £36–580 Royal Free/
Royal Shrewsbury
Blood tests and laboratory investigations 2.36 (3.93) 3.01 (4.57) £1.02–236.30 Royal Free/
Royal Shrewsbury
Other tests and investigations 0.39 (0.74) 0.46 (0.77) £2.58–989.68 Royal Free/
Royal Shrewsbury/
NHS Reference
Costs
Hospital services
Visits to outpatient departments 1.32 (1.57) 1.28 (1.59) £9–127 Royal Free/
Royal Shrewsbury/
Netten and
Curtis56/
NHS Reference
Costs
Inpatient admissions 0.11 (0.35) 0.13 (0.39) £76.33–218 Royal Free/
per day Royal Shrewsbury
Accident and emergency 0.06 (0.30) 0.06 (0.28) £111.91 Royal Free
Day surgery and other inpatient  0.11 (0.36) 0.12 (0.38) £28.62–4956 Royal Free/
procedures Royal Shrewsbury/
NHS Reference
Costs
Other hospital visits 0.07 (0.30) 0.12 (0.42) £9–70.94 Royal Free/
Royal Shrewsbury/
Netten and
Curtis56/
NHS Reference
Costs
Other hospital contacts 0.05 (0.26) 0.09 (0.36) £5.60–18.17 Netten and Curtis56
GP estimate
Prescriptions
Number of patients n = 852 n = 859
Prescriptions 8.72 (12.97) 8.15 (12.53) Computerised
records at GP
practicesHealth Technology Assessment 2004; Vol. 8: No. 50
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TABLE 11 Summary of costs (£), by sector
Mean (SD) Virtual outreach Standard Difference
Mean (SD) Mean (SD) (95% CI)
NHS costsa n = 1044 n = 1035
Index consultationb 162.96 39.14
Primary care visits and contactsc 75.11 (77.40) 70.41 (72.14) 4.70 (–1.74 to 11.14)
Secondary care visits and contactsc 188.76 (532.28) 208.08 (1068.86) –19.32 (–91.86 to 53.21)
Tests and proceduresc 182.21 (403.23) 209.23 (384.31) –27.02 (–60.90 to 6.87)
Prescription costsd 114.26 (206.48) 105.63 (173.62) 8.63 (–7.79 to 25.04)
Total NHS cost (imputed) 723.29 (832.04) 632.49 (1199.68) 90.80 (2.07 to 179.54)
Adjustede 93.87 (7.34 to 180.40)
Attributable NHS costs (imputed) 392.65 (388.88) 292.98 (407.15) 99.67 (65.42 to 133.91)
Adjustede 102.58 (68.87 to 136.29)
Patient costs n = 777 n = 820
Patient transport costsf 1.12 (3.06) 4.52 (8.18) –3.40 (–4.02 to –2.79)
Lost payg 2.53 (16.58) 6.46 (32.51) –3.93 (–6.48 to –1.38)
Patient childcare costsh 0.03 (0.37) 0.40 (3.93) 0.37 (0.09 to 0.64)
Total patient costs (imputed) 3.69 (16.89) 11.38 (33.85) –7.70 (–10.35 to –5.05)
Adjustede –7.65 (–10.30 to –5.01)
a These data exclude 15 patients who withdrew their consent from the study.
b 255 patients in the trial did not attend their index consultation; of these 155 patients in the virtual outreach group and 
70 patients in the standard outpatient group did not attend their index consultation. A zero cost has been assigned to the
index consultation for these patients.
c Values were imputed for 21 patients with missing data; the imputed value was the mean cost for patients with data. 
d Values were imputed for 368 patients with missing data; the imputed value was the mean cost for patients with data. 
e Adjusted for age at randomisation, gender, speciality, site and DUSOI total score (by missing indicator method).71
f Values were imputed for 163 patients with missing data. 
g Values were imputed for 12 patients with missing data.
h Values were imputed for 70 patients with missing data.
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FIGURE 5 Difference in mean total NHS cost (£) between virtual outreach and standard groupsspeciality effects existed for attributable resource
use. Table 13 shows that in urology, mean costs per
patient were lower in the virtual outreach group,
although this difference was not statistically
significant. However, in all other specialities, the
mean cost per patient was higher in virtual
outreach and this difference was statistically
significant. 
Patient costs
Patients’ questionnaires were returned by 1597
(77%) patients, 777 (74%) in the virtual outreach
group and 820 (79%) in the standard outpatient
group. The results are summarised in Table 10.
Patients in the virtual outreach group incurred
lower transport costs for the index consultation
than those in the standard outpatients group. The
mean difference in travel cost was £3.22 (95% CI
£2.56 to £3.88, p < 0.0001) and did not differ
across site. Mean travel costs were higher in the
Shrewsbury arm of the trial for both virtual
outreach and standard outpatient groups, but the
magnitude of difference between the two arms of
the trial was almost identical at both sites. In
addition, it was found that mean childcare costs
arising from the index consultation were £0.33
Economic evaluation results
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TABLE 12 Total NHS cost (imputed) (£), by site and speciality
Virtual outreach Standard Difference
(n = 1033) (n = 1025) (95% CI)
Mean (SD) Mean (SD)
Site
London (n = 1222) 725 (883) 583 (664) 142 (26 to 258)
Shrewsbury (n = 857) 721 (756) 703 (1694) 17 (–121 to 155)
Test of interaction p = 0.17
Speciality
Orthopaedics (n = 372) 700 (668) 469 (549) 231 (22 to 440)
Urology (n = 292) 826 (789) 955 (1060) –129 (–365 to 107)
ENT (n = 585) 662 (940) 598 (1963) 64 (–103 to 231)
Gastroenterology (n = 428) 716 (829) 654 (641) 61 (–134 to 256)
Other (n = 405) 767 (830) 578 (526) 189 (–12 to 389)
Test of interaction p = 0.19
TABLE 13 Total attributable NHS cost (£), by speciality
Virtual outreach Standard Difference
(n = 1033) (n = 1025) (95% CI)
Mean (SD) Mean (SD)
Orthopaedics (n = 372) 385 (393) 252 (463) 133 (53 to 213)
Urology (n = 292) 470 (499) 500 (575) –30 (–120 to 61)
ENT (n = 585) 384 (370) 264 (413) 120 (56 to 184)
Gastroenterology (n = 428) 365 (192) 286 (289) 79 (4 to 153)
Other (n = 405) 385 (465) 229 (211) 156 (79 to 233)
Test of interaction p = 0.023
TABLE 14 Cost (£) of tests and procedures, by speciality
Virtual outreach Standard Difference
(n = 1033) (n = 1025) (95% CI)
Mean (SD) Mean (SD)
Orthopaedics (n = 372) 145 (298) 148 (381) –3 (–82 to 76)
Urology (n = 292) 275 (421) 419 (590) –145 (–234 to –56)
ENT (n = 585) 160 (326) 169 (374) –9 (–72 to 54)
Gastroenterology (n = 428) 184 (425) 235 (268) –50 (–124 to 23)
Other (n = 405) 179 (524) 143 (236) 36 (–40 to 112)
Test of interaction p = 0.034(95% CI £0.05 to £0.61, p = 0.02) lower for virtual
outreach patients. Patients in the virtual outreach
arm also lost substantially less pay than those in
the standard outpatient group. The mean loss of
pay for virtual outreach group patients was £2.58
against a mean of £6.21 in the standard
outpatients group. The mean difference of £3.64
(95% CI £1.11 to £6.17, p < 0.01) was significant
at the 5% level. Total patient costs were
significantly lower in the virtual outreach arm,
with the mean difference between group being
£7.24 (95% CI £4.62 to £9.87, p < 0.0001). 
Productivity losses
Using data on the time that patients took
attending their index consultation, it was
estimated that virtual outreach led to reduced
potential productivity losses. The mean
improvement was £10.76 per patient (95% CI
£9.77 to £11.75, p < 0.0001). There was little
difference by site of the mean productivity loss;
the virtual outreach group was £10.09 higher in
London and £11.57 higher in Shrewsbury. Patients
in the virtual outreach group were also less likely
to have to take time off work to attend their index
consultation. In the standard outpatients group,
32.7% patients took time off work to attend their
index appointment compared with 25.5% in the
virtual outreach group. The difference was more
marked in Shrewsbury, with 12% fewer in the
virtual outreach group having to take time off
work, compared with 3% in London.
Sensitivity analysis
The results of the one-way sensitivity analysis are
shown in Table 15. Two costs are indicated for an
index teleconsultation. The lower value does not
include telecommunication costs, which would no
longer be incurred if the trial was conducted now,
as improved telecommunications facilities in the
health service mean that a virtual outreach service
could be offered over existing networks. Virtual
outreach appointments remained more expensive
under all scenarios presented here. Under most
scenarios, total costs to the NHS, based on
attributable resource use remained significantly
higher in the virtual outreach group. However,
with either very short teleconsultation duration or
reduced GP time the difference in total
attributable NHS costs just ceases to be statistically
significant at the 5% level (on the basis that the
service could be offered over existing health
service telecommunication networks at no extra
charge). The magnitude of the difference was
particularly sensitive to the duration of the
teleconsultation, reflecting the implications that
this has for two clinicians’ time. Relaxation of the
assumption that non-attendance at appointments
did not result in any costs being incurred
increased the cost of virtual outreach
Health Technology Assessment 2004; Vol. 8: No. 50
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TABLE 15 One-way sensitivity analysis
Cost of index consultation
Parameter Default Range Virtual Virtual Standard
outreach outreach (1)a outpatient
Consultant time, conventional appointment  11.8 11–19 £164 £123 £30
(minutes) £164 £123 £51
Teleconsultation duration (minutes) 10.5 3–22 £132 £92 £32
£212 £171 £32
GP time, teleconsultation (includes  26 10.5–35.5 £138 £97 £32
10.5-minute consultation) (minutes) £179 £139 £32
Consultant time, teleconsultation (includes  19 10.5–30.5 £140 £100 $32
10.5-minute consultation) (minutes) £190 £149 £32
Videoconferencing equipment (£) 52,000 10,000–100,000 £147 £107 £32
£182 £141 £32
Videoconferencing equipment lifespan (years) 5 1–7 £233 £193 £32
£159 £118 £32
Teleconsultations per annum 500 100–10,000 £244 £204 £32
£144 £103 £32
a Virtual outreach (1): as virtual outreach but assumes that the service can be offered over the existing NHS
telecommunications network.appointments relative to conventional ones. This
was because there was a greater prevalence of non-
attendance in the virtual outreach group, and also
because any opportunity costs associated with non-
attendance were likely to be greater for
teleconsultations than for conventional outpatient
appointments. 
Under the best case scenario (Table 16), virtual
outreach consultations were only £23 more
expensive than conventional outpatient
appointments, and no significant difference exists
between total attributable NHS costs for the
virtual outreach and standard outpatient 
groups.
Economic evaluation results
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TABLE 16 Multiway sensitivity analysis (virtual outreach best case)
Parameter Default Best case Virtual Virtual Standard
outreach outreach (1)a outpatient
Number of consultations 500 10,000
Teleconsultation duration (minutes) 10.5 7
GP time (excluding teleconsultation duration)  15.5 13
(minutes)
Consultant time (excluding teleconsultation  9.4 5 £114 £74 £51
duration) (minutes)
Consultant time, conventional (minutes) 11.8 19
Videoconferencing equipment (£) 52,500 30,000
a Virtual outreach (1): as virtual outreach but assumes that the service can be offered over the existing NHS
telecommunications network.I
t had been hypothesised that, as in the case of
actual joint consultations reported by Vierhout
and colleagues,35 the ability of the GPs and
consultants to review the patients together would
have resulted in better communication, leading to
more effective management and fewer patients
being asked to return to outpatients for
subsequent review. However, in general, patients
seen in virtual outreach were more frequently
offered follow-up than those who underwent a
standard outpatient consultation. These results
showed statistically significant heterogeneity for
both speciality and site. Increased offer of follow-
up was highest in the surgical specialities (ENT,
orthopaedics and urology) and was not seen in
gastroenterology or the other medical specialities.
While it seems likely that the difference between
specialities was largely a reflection of the different
requirements of the consultations (surgical
specialities having a greater requirement for direct
‘hands-on’ examination), it may also be that the
findings were confounded by the characteristics of
the individual specialists involved, especially as the
numbers of those in each speciality were relatively
small. It was also higher for those patients seen by
specialists based at the Royal Shrewsbury Hospital
than for those based at the Royal Free Hampstead
NHS Trust, even following adjustment for the
different specialities participating at each of the
two sites. This suggests that there may have been
different norms for offer of follow-up appointments
between the two hospitals, although a review of
records for routine outpatient appointments
before the trial did not show any evidence of such
differences. Furthermore, the ITT analysis was
conservative, in that more of those randomised to
virtual outreach than standard outpatients did not
receive the index appointment and therefore were
considered to have been offered a follow-up
appointment. The per protocol analysis of those
who received the intervention to which they were
randomised showed a smaller difference between
the groups.
While offering a novel opportunity for the GPs
and hospital specialists to share their medical
expertise, the virtual outreach consultation posed
significant challenges for the participants. It
required GPs to be present at their patients’
consultations, whereas specialists were obliged to
conduct their consultations at a distance. Many
specialists may have felt uneasy at having to rely
on the GPs’ clinical findings, and this was
particularly relevant in ENT and orthopaedics,
where specialised examination techniques may
require skills and access to instrumentation
beyond the scope of most of the GPs. The
specialists’ perceived need to undertake the
physical examination themselves is likely to
explain a substantial part of the increase in offers
of follow-up appointment found in the trial, and
for most of those virtual outreach consultations
that were considered to be inappropriate by the
specialists. This explanation is given support by a
qualitative study carried out in parallel to the
main trial,73 which confirmed the problems posed
in some cases by remote consultation. The
persistence of the significant differences in the
frequency of offer of follow-up between
randomised groups in London and Shrewsbury
following adjustment for the specialities
participating in the trial at each hospital may have
been due to different settings. In general,
telemedicine applications have been more widely
implemented in countries with dispersed rural
populations, and there is some evidence that they
are most cost-effective in such settings.74 Indeed,
this was the rationale for carrying out the London
and Shrewsbury arms of the trial. However, there
were few differences between the patients entered
in the trial at the two sites, and there was no
evidence of systematic differences in the operation
of the outpatient systems at the two hospitals. It
therefore seems much more likely that the findings
resulted from differences between clinicians.
Because of the relatively small numbers of
participating specialists, it was not possible to
determine the relationship between rates of offer
of follow-up and attitudes towards virtual outreach
and dealing with clinical uncertainty,75 but it
seems probable that these factors played an
important role. 
The lack of any difference in overall numbers of
attendances at outpatients between the two groups
contrasts with the increased frequency of offer of a
follow-up appointment to the virtual outreach
group. However, the findings of increased offer of
a follow-up consultation and increased numbers of
outpatient appointments in patients referred to
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Chapter 5
Discussionorthopaedics receiving virtual outreach are
consistent, and the authors have no reason to
believe that there was any systematic under-
recording of actual outpatient attendances. Some
offers of outpatient follow-up were clearly not
translated into actual attendances, perhaps in part
because the results of investigations requested at
the index consultation subsequently became
available and suggested that an appointment was,
after all, unnecessary. Virtual outreach had been
expected to reduce the need for patients to
consult their GPs to clarify the outcome of their
outpatient consultation, or for medication
recommended by the specialist. However, it was
also expected to enable as many patients as
possible to continue to be managed in primary
care, rather than being transferred to outpatients.
These two effects may have operated to the same
degree in opposite directions, thus resulting in the
lack of difference found in the trial.
The trial demonstrated significant reductions in
tests and investigations performed on patients
seen in virtual outreach. This is in line with the
findings of the joint consultations study carried
out by Vierhout and colleagues,35 and suggests
that virtual outreach enabled the participating
clinicians to be more efficient in undertaking
patient investigation, probably largely by avoiding
unnecessary duplication. This is supported by
findings from the qualitative study,73 which
indicated that during the virtual outreach
consultations, the GPs were able to supply the
hospital specialists with information from the
general practice record about recent tests and
investigations. The reduction in tests and
investigations is likely to be important, both in
terms of resource savings for the health service,76
and in reducing inconvenience, discomfort and
possibly risk for the patients involved. 
The lack of difference in prescription rates
between the two arms of the trial was not
unexpected, and it is likely that it was influenced
unduly by the methodological limitations of the
study. The analysis relating to rates of prescribing
was inevitably compromised by the failure to
collect prescription data from all of the
participating practices. However, it is unlikely that
the missing data constituted a significant problem.
First, patients were not randomised by practice,
and therefore missing data were evenly distributed
across both arms of the trial. Indeed, there were
no systematic differences in prescription data
collected between the virtual outreach group 
(n = 852) and the standard outpatient group 
(n = 859). Second, underestimation of the
variances (standard errors) would have led to a
greater confidence than was warranted in the
difference in means between the two arms of the
trial. This would have been important if
statistically significant results had been found;
however, the null hypothesis that the difference
was due to chance could not be rejected 
(p = 0.30), even with the possibility that the
variance had been underestimated.
Patient satisfaction was consistently higher in the
virtual outreach group, across all the parameters
measured by the Ware SVQ, and apparently
independent of the outcome of the consultation.
Although some smaller studies have produced
similar findings, the validity of these results has
been rightly questioned,77 and to the authors’
knowledge this is the first time that a properly
conducted trial of adequate size has been able to
provide such strong evidence of this effect. The
convenience of the site and timing of the
consultation appeared to contribute, as did the
attitude of primary care reception staff. The
higher ratings for these and other items relating
to customer care may well have been responsible
for the difference in the overall satisfaction ratings
given by the virtual outreach patients. However,
satisfaction ratings were also higher for those
subscales relating to physician behaviour,
indicating that patients felt that the clinical
content of the consultation was of greater quality.
In addition to the opportunity for their problem
to be discussed by two physicians, many patients
may have been more relaxed in a consultation
carried out in the familiar setting of their local
surgery, and in the presence of their GP.
Favourable behavioural responses obtained in an
experimental setting are often not repeated in the
context of routine service. Hence, although
patients were very positive about the joint
teleconsultations in this study, this would not
necessarily be the case in routine service. Although
this may have been the case, it seems likely that
items in the SQ such as convenience, waiting
rooms and staff attitudes may well endure over
time, even if such consultations became
commonplace in GP surgeries. It is more difficult
to know whether the higher ratings for the actual
consultation would persist, although the patients’
perceptions of having more attention and feeling
more confident that the specialist had a full
understanding of their medical condition seem
unlikely to be susceptible to change with time.
Indeed, with training, especially for GPs, and a
more discriminating selection of patients for
referral, satisfaction may be sustainable at even
greater levels.
Discussion
34In the present study, enablement as measured by
the PEI did not show any appreciable differences
between the two groups, irrespective of site or
speciality. Overall, scores were similar to the mean
score reported by Howie and colleagues for GPs in
conventional general practice consultations.62
Patient enablement is related to satisfaction, but is
different in that it is a measure of patients’
perceptions of their ability to cope with their
health problems following a consultation. The PEI
scale was developed specifically for general
practice consultations. To the authors’ knowledge
it had not been used previously in the context of
either standard outpatients or joint consultations,
but following the start of the trial, a report
appeared of its use in a hospital outpatients
department, which found a mean score of 47,
some 50% higher than either Howie63 or the
present results.78 Many factors in the consultation
have been found to correlate with enablement,
including length of consultation and continuity of
care,79 but the recent outpatient study suggests
that the patient’s expectation, the doctor’s
empathy (as perceived by the patient) and the
doctor’s own confidence in the therapeutic
relationship are key factors. Problems in
communication that the virtual outreach
consultations posed for many of the clinicians may
have interfered with their ability to convey
genuine empathy or to communicate confidence
in the therapeutic relationship with the patient.
The question of the potential for virtual outreach
to help or hinder patient enablement remains
open, but it is reassuring that patients seen in this
way fared no worse than those seen in the
standard outpatients setting. 
This study did not find difference in the measures
of quality of life, such as those found in the
Vierhout study,35 but this may have been because
of differences in case-mix and the nature of the
consultations.
For this study, a cost–consequences approach was
adopted for the economic evaluation. In economic
evaluations, the cost–consequences approach is
considered a variant of cost-effectiveness analysis,80
but it does not use the cost-effectiveness ratios
associated with that technique. It was chosen
because the multidimensional character of the
outcomes made aggregation difficult. First, health
outcomes were measured using SF-12, and such
generic health surveys are of limited value in the
context of an economic evaluation, because they do
not indicate the value placed on any change in
outcome. Attempts are being made to convert such
scores into a preference-based measure, but such
algorithms for SF-12 remain in the development
stage (Brazier JE, University of Sheffield: personal
communication, 2002). Furthermore, this study was
also interested in patient satisfaction. It is not
possible to combine these measures to form a
single effectiveness measure. A contingent
valuation study (such as WTP) may have been used
as part of a cost–benefit analysis. However, this
technique is still in a developmental stage and
would have required additional surveys of
participating patients, who had already been
required to fill in a large number of questionnaires.
The effects of virtual outreach on NHS costs have
to be interpreted with caution. The analysis based
on total use (as opposed to attributable resource
use) suggests that overall the mean cost per
patient was £91 higher in the virtual outreach
group than in the standard outpatients group, and
that this difference was just significant at the 5%
level. Thus, the initial hypothesis that virtual
outreach would not lead to increased costs in the
NHS was not supported. Furthermore, when the
analysis was restricted to attributable resource
data, the mean cost per patient was £100 more in
the virtual outreach project, but was now highly
significant. The similarity in the mean difference
between the two approaches suggests that the
attributable data excluded a similar number of
resource items from both arms of the trial.
However, this attributable analysis is likely to
reflect more accurately the true position, because
of the noise inherent in an analysis based on total
resource use. 
The definition of attributable for a particular
resource item was governed by what was practical
and robust. For example, a chest X-ray is unlikely
to be attributable to an index consultation in the
virtual outreach project, because of the specialities
involved. The same method of attribution was
used in Shrewsbury and London. However, an
additional exercise was undertaken in Shrewsbury,
in which the research nurses attempted to
attribute resource items using their clinical
judgement. The analysis of this data indicated
very similar results to the reported attribution
method. In the case of prescriptions, it would have
been impractical to use clinical judgement to
review each of the 14,427 prescriptions issued in
the 6 months following the index consultation,
and the attribution method used was thus
necessarily automated. Nonetheless, the validation
exercise undertaken by a clinician on a subset of
data suggested that the lack of clinical input into
this method of attribution did not lead to any
substantial reduction in accuracy. Although it
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positives and false negatives, there would have
been no systematic differences in these effects
between the two arms of the trial.
The hypothesis that virtual outreach would not
lead to increased costs to the NHS was based on
the expectation that better patient management
arising from improved communication would lead
to downstream savings. The results as presented
here do not provide evidence that such savings
exist. In the paper on the clinical findings
published in the Lancet, it was reported that
virtual outreach led to a significant reduction in
tests and investigations.55 This study found a
downstream saving to the NHS of about £4 per
case (based on analysis of either total or
attributable resource use) arising from this
reduction in the number of tests. The difference
in costs was not as marked as the difference in the
number of tests, as the greatest difference in tests
and investigations between the two groups
occurred in low-cost routine tests. For statistical
analysis it was necessary to pool resource
categories, and the real, but small cost savings
from reduced tests could no longer be detected
when combined with resource use data on hospital
procedures. It may be that additional resource
savings would have accrued beyond the 6-month
assessment limit used in the trial. This is an area
that merits further investigation. 
This trial suggests that downstream savings,
arising from better patient management, would
have had to be large to compensate for the costs
of a consultation using two physicians. However,
sensitivity analysis highlighted that the cost
difference between the two consultation types was
sensitive to a number of parameters. The trial was
pragmatic and avoided undue constraints on the
participating clinicians, but the introduction of the
technique into routine practice may differ from
the trial setting. For example, increasing
familiarity with the technology and service type
may lead to improvements in the delivery of
virtual outreach consultations. The educational
value of the joint teleconsultations could lead to
improved primary care management and different
referral patterns by the GPs. However, because of
the relatively small number of teleconsultations
that the participating GPs undertook in each
speciality area, such an effect would have been too
small to detect in the trial. Technical failures of
virtual outreach are likely to be a function of
training, experience and the state of technology,
and could be reduced, so leading to less inefficient
use of physician time.
There are several reasons why the ingredients-
based cost used in the analysis could have
overestimated costs. First, the average cost of a
virtual outreach consultation is in some respects
an artefact of the trial itself. The capital and
overhead costs are essentially fixed, and therefore
the fixed cost per consultation depends crucially
on the number of consultations undertaken.81 The
marginal cost of a consultation has been included
in Table 3, because it removes considerations of
volume. Nevertheless, the sensitivity analysis
demonstrated that at 500 consultations per
annum, the volume passes the threshold where
significant economies of scale remain available.
Second, ISDN lines and videoconferencing
equipment had to be installed and purchased
specifically for the purposes of the trial. It seems
likely that in the future, a virtual outreach service
would ‘piggyback’ onto the existing IT and
telecommunications facilities of the hospital and
GP practice. For example, the Digital All Wales
Network is now configured to support
videoconferencing with a 256 kilobit link into
every GP practice. In England NHSnet 2 is likely
to offer a similar service, with a central payment
made for as much bandwidth as the NHS can take.
Therefore, only a proportion of these capital costs
would be assigned to virtual outreach and so the
marginal telecommunication costs would approach
zero. Finally, the problems of evaluating an
emerging health technology have been well
documented. By evaluating the teleconsultations
at a fixed point in time, the study could not
incorporate changes in the prices of IT and
telecommunications equipment, which are likely to
fall and thus reduce the capital costs of
consultation. Although the potential effects of this
are included in the sensitivity analysis, an
evaluation of any new technology may be criticised
for not reflecting potential improvements.
Innovative service provision could lead to
economies of scale and scope beyond those
outlined above, which would further lower the
average cost of a consultation.
The higher costs in virtual outreach are entirely
accounted for by the difference in the costs of the
index consultation, and a key finding of the
economic evaluation of the trial was the large cost
difference between a conventional outpatient
appointment and a virtual outreach consultation.
This was therefore used as the prime factor in the
sensitivity analysis. In the analysis, a traditional
approach was adopted, using a range of values for
parameters and considering the effect of altering
these parameters within this range individually
(univariate/one-way sensitivity analysis) or in
Discussion
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sensitivity analysis: the ‘best case’). There has been
increasing interest in methods for probabilistic
sensitivity analysis that involve assigning a
distribution to each of the parameters. However,
these methods are usually used where an
incremental cost-effectiveness ratio is being
calculated within a model. In a cost–consequence
approach, costs are considered alongside an array
of outputs. The key driver of the costs of both
consultation types was the duration of clinician
involvement. However, this was also the principal
source of uncertainty in the analysis, given the
small sample of non-random consultations
observed. Therefore, the most important aspect of
the sensitivity analysis was to see how sensitive the
findings were to different types of clinician input.
With the baseline data, the results were
unfavourable to the adoption of virtual outreach,
and therefore it was appropriate to bias the
sensitivity analysis against the most favourable
strategy, in this case conventional outpatient
consultations.82 To do otherwise would simply
strengthen the baseline conclusion.
If the index consultation was excluded from the
analysis then the mean differences in costs for
prescriptions, primary care contacts, secondary
care contacts, and tests and procedures were not
significant at the 5% level. These data are ‘noisy’,
as much of the recorded use of NHS resources will
be unrelated to the index consultation. An attempt
was made to overcome this problem by attributing
resource items to the index consultation, but it
may be this did not pick up real changes in
patient management. It is also possible that 
6 months of follow-up may be insufficient to detect
downstream savings as a result of changes in
patient management. Furthermore, if the virtual
outreach consultation is of educational value to
GPs, patients other than those in the trial stand to
benefit from improved management in the
primary care setting. These potential cost savings
to the NHS could not be captured by this study.
Whatever the assumptions made in this study, the
hypothesis that virtual outreach would not lead to
increased NHS costs is not supported by the
results. This finding that virtual outreach
consultations are considerably more expensive
than standard outpatients makes it unlikely that
policy makers will be persuaded that it is worth
adopting, especially as no resulting health gains
were detected.
This study demonstrated that patients attending a
teleconsultation incur significantly lower transport
costs than those attending conventional outpatient
appointments, although the magnitude of the
difference (£3) was relatively small. Thus, the
second hypothesis was supported. The results are
similar to those obtained in another RCT of
telemedicine.53 A total of 138 patients reported
that they incurred transport costs, but did not
record an amount. However, 742 patients reported
that they incurred no transport costs, including 
89 patients in the Shrewsbury standard 
outpatients group. This suggests that there may
have been some under-reporting of transport
costs. This study also found that patients in the
virtual outreach group lost significantly less pay.
Overall, this study provides strong evidence of
financial benefits to patients in attending a
teleconsultation appointment, compared with a
conventional outpatient appointment. Patients in
the virtual outreach group reported times off work
that were significantly shorter than for those in the
standard outpatient group. However, the
distribution of the answers to the questions
suggests that some respondents may have
interpreted the question as referring solely to
travel time. Nonetheless, the trial results provide
good evidence that virtual outreach consultations
consume less patient time, and are thus likely to
have a positive impact on productivity. This is also
supported by the results of the patient
questionnaire, showing that the proportion of
patients in the virtual outreach group who
reported taking time off work was lower than in
the standard outpatients group. This is further
evidence of the potential benefits of virtual
outreach to economic activity, thus supporting the
third hypothesis. Time loss is suggestive of
productivity loss, not firm evidence of actual loss.
There is the possibility that some productivity is
lost forever, but some is made up later by the
worker or by other workers working harder.
Patient/productivity costs for the 6-month period
after the index consultation were not examined,
because of the difficulties involved in collecting
such comprehensive data for approximately 
2000 patients. As it was, trial patients were asked
to fill in many questionnaires. Ascertaining a 
large amount of additional information on the
costs that they had incurred for every NHS
resource item used would have imposed an unfair
burden on the patients. Furthermore, as no
significant differences were found in 6-month
NHS resource use (excluding the index
consultation), it seems unlikely that patients’
private costs would differ significantly. Had
significant differences in downstream NHS
resource use been found, it would have certainly
been worth modelling the possible impact of this
on patient costs/productivity. 
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were not in a position to select the types of patient
included, it may have underestimated the benefits
that virtual outreach could deliver to appropriately
selected patients. However, by keeping the
inclusion criteria broad and by including a
number of specialities in the trial, evidence was
obtained that suggests that some specialities may
be generally less appropriate for virtual outreach
than others. It may be that the conservative
approach adopted in the ITT analysis on offer of
follow-up has unduly weighted the findings against
virtual outreach. Nonetheless, the overall
difference in the offer of follow-up between
randomised groups was small, and even in those
specialities where significant differences were
found, a substantial proportion of patients seen in
virtual outreach did not need a follow-up
appointment. This suggests that appropriately
selected patients in these specialities may well be
suitable for virtual outreach. This study assessed a
technology which is rapidly evolving, resulting in
reduced costs, improved reliability, ease of use and
quality of transmission, all of which are likely to
make virtual outreach more practicable in the
future. Increasing familiarity with the equipment
will probably change professional attitudes and
reduce the time required to set up consultations,
thus reducing costs. In settings where joint
teleconsultations are particularly indicated, for
example, in dispersed rural populations, it may
become feasible to provide enhanced training for
GPs to undertake specialist examinations in areas
such as orthopaedics and ENT, and to equip
primary care sites with peripherals, instruments
such as fibre-optic scoping devices, which would
enable remote visualisation by the specialist in the
context of the virtual outreach examination.83
The finding that the initial virtual outreach
consultation is more expensive than the
conventional alternative does not necessarily mean
that in the longer term virtual outreach would be
more expensive. Downstream savings could result
from the educational benefit derived from joint
consultations and improved communication,
leading to better patient management. There is
some evidence in this study that joint
consultations may reduce unnecessary follow-up
and the number of tests and investigations. There
are management implications of this for
conventional clinical appointments. 
This was a pragmatic trial; as yet, the NHS does
not offer virtual outreach appointments and the
delivery of such a service routinely may differ from
the service delivered as part of the trial protocol.
The study has, however, produced a number of
important and interesting findings. Conventional
wisdom suggests that telemedicine applications are
best suited to environments where patients are
separated by distance from medical care.54
However, this trial found that virtual outreach
patients in an inner-city setting achieved as great a
saving in the travel costs of attending their index
consultation as those in the Shrewsbury arm,
which included rural areas and small market
towns. This suggests that the convenience that
virtual outreach offers to patients is not solely
contingent on their distance from the hospital.
Nor does virtual outreach depend solely on
generating cost savings for the NHS. The cost-
effectiveness of healthcare depends on its
outcomes as well as its costs. The trial found that
there were no statistically significant differences in
health status between the patients at 6 months, but
that the virtual outreach group had higher levels
of satisfaction than the standard outpatient group
and that difference was statistically significant at
the 5% level. A WTP study could be used to
explore whether the extra satisfaction generated
by virtual outreach was worth the additional cost.
Further exploration of this is recommended as an
area for future research. Increased patient
satisfaction has been reported in other
telemedicine studies.43,84 This study strongly
suggests that virtual outreach may reduce societal
costs outside the NHS, for example through lower
patient transport costs and a positive impact on
productivity. Optimal resource allocation depends
on a societal perspective and the economic case
for virtual outreach would be improved under this
broader approach. However, this study has not
established that virtual outreach is more cost-
effective than conventional consultations with a
hospital specialist.
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his trial has demonstrated that virtual
outreach consultations result in significantly
higher levels of patient satisfaction than standard
outpatient appointments and lead to substantial
reductions in numbers of tests and investigations,
but that they are variably associated with increased
rates of offer of follow-up according to speciality
and site. The main hypothesis that virtual
outreach would be cost neutral is not supported,
but the hypotheses that patient costs and
productivity losses would be less were supported.
Changes in costs and technological advances may
improve the relative position of virtual
consultations in future.
These findings have important implications for
the design and implementation of virtual outreach
services within healthcare systems, and suggest
that several key factors need to be taken into
account in planning the implementation of such
services. Appropriate patient selection, significant
service reorganisation, and provision of logistical
support for arranging and conducting
consultations will be required to enable such
services to operate efficiently. Clearly, these factors
will be very important in designing services that
could be successfully incorporated into routine
health service provision. However, a wealth of
evidence is available that indicates that whatever
the evidence on effectiveness, the incorporation
and normalisation of such systems depend on
additional factors.85 The extent to which virtual
outreach is implemented is thus likely to be
dependent on factors such as patient demand,
costs, and the attitudes of staff working in general
practice and hospital settings. Further research is
needed on the use of virtual outreach for other
purposes, such as follow-up appointments, and
this report does not take into account potential
educational benefits for clinical participants, which
are the subject of qualitative research to be
reported elsewhere.
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Chapter 6
ConclusionsWe should like to thank all the patients and staff
who participated in the trial (see Appendix 8).
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Timetable
1.10.96 Project office starts processing letters
through hospital computer to generate
appointments. Non-participating GPs’
and non-participating consultants’
letters fed back into normal hospital
administration
20.10.96 Teleconsult appointments can be
anticipated from here on
23 or 29 October Training day
20 or 26 November Training day
17 or 18 December Training day
22 or 28 January Training day
25 or 26 February Training day
GP Practice Admin Guidelines
1. GPs dictate referral letters
2. Secretary types and, after signature, posts all
Royal Free letters to: 
Ms Marcia Rigby
Virtual Outreach Project
Dept of Primary Care
Royal Free Hospital School of Medicine
Rowland Hill Street
LONDON NW3 2PF
3. Practice appointments desk receives call from
project office to book appointment in GP’s
surgery diary. This will usually be an early
morning appointment. ISDN phone number to
be dialled will also be noted in the
appointment book.
4. Project office confirms with patient by phone.
5. Patient receives information pack,
questionnaire and consent form. Relevant items
returned to Virtual Outreach Office in SAE.
6. Patient attends practice for appointment.
Practice member makes call to relevant
outpatients at the appointment time to set up
the link, calls GP when ready.
7. Practice receives severity of illness score sheet
(DUSOI) for some patients, placed with notes
in doctor’s file for them to complete.
Equipment guidelines
Starting the machine
Power and ISDN telephone connection are
required, then you need to switch on the computer
and open the teleconferencing program (known as
PCC). To do this:
1. Check the power lead is plugged into mains,
and phone lead plugged into the ISDN socket.
2. Switch on power at the mains then switch on
the computer (red button on computer box).
The phone will bleep when powered up.
3. The computer will start up and automatically
open the PCC program as far as PCC Desk. Do
not touch the controls while this is happening,
it takes a minute or two.
4. The program is designed to receive calls
automatically from this display.
5. To make a video call, select the CallDesk button
from the PCC Desk using the mouse to press
the button once. Double click on consultant
name to pull up their usual ISDN number,
double click on the number and this will
transfer it to FCC Desk.
6. With the correct number in the number field
(you can also type it in) click on the Video Talk
button and drag it onto the Call button. This
will make the call; it takes a few seconds. The
clinic should be on automatic answer; if there is
no ring tone they may not be switched on, in
which case a call to the clinic, see Fallback
Procedures, page 6, will remind them.
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GP training manualTo close down the system
It is important to close down all the programs
before switching off.
1. The top right of PCC Desk has a button with a
cross, press this to close the PCC program.
2. Press the Start button in the bottom left corner
of your screen and then press Shutdown. Press
Yes to confirm this instruction. You will get a
message when shutdown is complete to say it is
safe to switch off. Use the red button on the
computer and then switch off at the wall.
Using PCC
The system is configured to receive calls when
PCC is open. The clinics are instructed to await
your call. It is helpful to set up the connection a
few minutes early so that everyone is prepared.
The system is usually used hands free; if you pick
up the handset during a call, perhaps because you
want to hear the consultant in private, be sure to
press hands-free button on the phone before
replacing the handset or you will cut off the call.
The speaker unit has two buttons to adjust the
volume up or down. To help cancel out
background noise if you are calling from a noisy
environment, press and hold down both buttons
for three seconds until the green light starts
flashing.
Practice calls to the project office are welcome.
Our ISDN number is 0207 794 2758.
To make a call
1. Press the CallDesk button on the PCC Desk.
Title bar
Call Desk Number fieldCall
Call End
2. In the CallDesk window double click with the
left mouse button on the consultant’s name.
3. Then double click on their phone number. This
will copy this number into the call field on PCC
Desk.
4. Click and drag the VideoTalk button over to the
Call button and release the button.
5. PCC will now call the selected Teleclinic. Wait
for them to answer; it takes about thirty
seconds for their image to appear after they
have picked up the call. If you have selected
self-view you will only see yourself. Change the
VideoTalk options to deselect self-view.
Fallback procedures
1. If you cannot get through on time
(a) call through to the clinic by dialling the
hospital, 0207 794 0500, and asking for the
relevant clinic:
Mr Morgan Clinic 1 3359
Dr Epstein Clinic 4 4648
Mr Quiney Clinic 5 5092/5312
Paediatrics Clinic 5 5312
Dr Bouloux Clinic 1 3359
Mr Kaisary Prostate lab 5494
Mr Goddard Fracture clinic 4046
Ms Eastwood Fracture clinic 4046
Prof. Black Rheumatology 4620
Dr Beynon Rheumatology 4620
(b) still problems? Ring project office, 
0207 830 2482, or
(c) call the hospital on 0207 794 0500 and
bleep project liaison. Bleep number 529
(Dr Clayton).
2. If you have difficulties using the software call
the project office.
3. If you have problems with the software not
running properly,
(a) close down PCC Desk.
(b) reboot the computer (via the Start button
and shutdown).
4. If a call is lost, return to PCC Desk, type in the
number and click call button, or use CallDesk as
before.
5. If unable to re-establish link or unable to power
up computer or run the software, ring the
project office or bleep 529.
Completing the DUSOI
Ideally, the DUSOI should be completed by the
doctor immediately after seeing the patient or
immediately after completing the medical record.
It may be completed subsequently, however, using
the patient’s record.
The DUSOI is important as it provides a measure
of the degree of illness in the two groups in the
study; if the randomisation has been successful
they should be the same.
Health problems
Record all the patient’s current health problems.
Current health problems include all those present
within the week preceding the visit. Chronic and
ISDN kbps 64 Bwidth
Time _________ Charges
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48acute illnesses should be included. The order in
which they are written does not matter. If a
diagnosis is not clear then state the most
prominent symptom.
Do not infer anything from the medical records
that you do not have personal knowledge of, even
if you think there has been an error.
If an ‘either/or’ diagnosis has been recorded,
record the principal symptom or problem.
Rating
Basically, the advice is not to think too much
about rating. It is accepted and works satisfactorily
on the basis of subjective judgements. Each item is
scored on a severity score 0–4.
1. Severity
Doctor’s judgement of severity at the time of
visit or one week before.
2. Complications
Again this is rated subjectively for the day of
the visit or previous week. NB. If the
complication results in another diagnosis do
not enter it as a complication; enter it as
another diagnosis, otherwise it will be counted
twice.
3. Prognosis
Assess the threat to life in the next six months
if untreated.
4. Treatability
This is based upon the need for treatment and
the expected response to treatment. It is
important that you provide a score for each of
the four items. Although the questionnaire
requires a degree of judgement, use of the
DUSOI shows that variability in ratings is
ironed out by overall scores.
If you want to know more about the way the final
DUSOI is calculated, this information is available.
The research office will also be pleased to let
individual GPs know in confidence how your
referral pattern has changed, if at all, during the
course of the trial.
Example DUSOI
(See Appendix 3.)
Project overview
The Virtual Outreach Project: a randomised
controlled trial and economic appraisal of
teleconferenced joint consultations between
general practitioners, patients and specialists.
1. Project summary and objectives
The project represents the planned extension of
the work of the feasibility study of teleconferenced
medical consultations funded by the National
R&D Programme. A randomised controlled trial
involving 15 group general practices is planned to
determine the effectiveness in selected clinical
areas of virtual outreach consultations compared
with conventional outpatient consultations. The
principal objective of the trial will be to evaluate
the relative impact of the two modes of
consultation on patient welfare and health service
usage. The study will also develop an analytical
framework for an economic appraisal of virtual
outreach and conventional outpatient
consultations, and their relative performance
compared to the quality of doctor–patient
communication, participant satisfaction, health
outcomes and use of health service resources. The
current phase is the piloting of the research
design.
2. Benefits the proposed
investigation will bring the NHS
There is now good evidence that joint medical
consultations (where hospital specialists and
general practitioners review patients together) can
lead to a substantial reduction in subsequent
outpatient referral and further health service
usage as well as an improvement in health
outcomes for the patient and in educational value
for the general practitioner (GP).1 However, with
the exception of joint domiciliary consultations,
there have been relatively few attempts to establish
facilities for joint consultation within the NHS.
Despite early enthusiasm, conventional outreach
clinics have failed to fulfill their promise. This
appears to be largely because of the inconvenience
to hospital specialists of having to travel to general
practices, and because of the failure in the great
majority of cases to establish proper communication
between hospital specialists and GPs.2
Our feasibility study has demonstrated clearly the
unique opportunity which teleconferencing offers
despite its current technical limitations. Joint
consultations can readily be achieved without the
need for either GP or consultant to leave their
usual place of work. Moreover, we now have firm
indications that the virtual outreach service is
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that it will be popular for clinical and educational
reasons with both GPs and hospital specialists.
Virtual outreach could thus constitute a natural
and potentially major application for the NHS
Health Technologies initiative, with its ability to
provide GPs and hospital consultants ready access
to multimedia terminals linked through HealthNet.
3. Background to the study
Referrals from general practice form a major part
of the workload at the interface between primary
and secondary care, with around 6–10% of
consultations in general practice resulting in a
referral and up to 20% of patients who consult
GPs in a year being referred to specialists.
Nationally there are an estimated 40,000
outpatient consultations each day, of which a
substantial proportion result from new referrals
from general practice.3
Key findings of the feasibility study include the
following:
  Virtual outreach is both feasible and practical
and can be readily arranged as a comprehensive
service for general practice.
  Virtual outreach was popular with all three
groups of participants, patients, specialists and
GPs.
  Virtual outreach appears to be an appropriate
alternative to routine outpatients in a large
proportion of referred patients and in a wide
variety of specialities.
  Virtual outreach can offer substantial
educational benefits for GPs, patients and
hospital specialists.
  A randomised controlled trial to evaluate the
relative value of virtual outreach and routine
outpatient referral is feasible.
4. Plan of investigation including
research methodology proposed
We have elected to undertake a randomised
controlled trial (RCT) in order to carry out a
rigorous evaluation of virtual outreach relative to
conventional outpatient referral. This will be
preceded by a pilot phase.
Recruitment of general practitioners
and consultants
General practitioners will be recruited to the study
on the basis of an agreement to allow allocation of
all their eligible patients in the identified
specialities to be seen by virtual outreach and a
commitment to participate in all the virtual
outreach consultations (up to 3 per week)
arranged for their patients during the study
period. Preference will be given to general
practitioners who have participated successfully in
the feasibility study as well as to those operating in
practices where three or more full-time partners
wish to participate in the study and where there is
existing compatible teleconferencing equipment.
Practices with an established relationship with the
Royal Free will also be recruited preferentially.
Participating GPs will be required to make a
considerable commitment to participate in the
research. This will include learning to use the
equipment, attending monthly discussion groups
and undertaking the joint consultations from the
practice. The GPs will require adequate
recompense to cover costs.
Randomisation
In order to ensure that both GP and patient
outcomes can be evaluated in the trial, the unit of
randomisation for the study will be participating
GPs (see below). Each GP will be allocated on a
Latin square basis a random selection of 50% of
the consultants identified for the study, with whom
to undertake joint virtual outreach consultations.
For all other areas, they will continue to have
access only to the routine outpatient service. This
experimental design will give the study the
potential to evaluate the impact of a virtual
outreach service, both for patients and for general
practitioners.
Recruitment of subjects
For the duration of the study, all patients referred
for a specialist opinion from the identified
consultants by the participating GPs will be
potentially eligible for recruitment to the study.
The criteria for inclusion in the study will be:
  routine referral principally for diagnosis
  referral primarily for advice about management
where decisions can be made on the basis of a
history and tests
  referral for medical intervention(s) to which the
GP does not have direct access (such as MRI
scan, endoscopic investigation, etc.)
  emergency referrals will be excluded.
All referral letters to the Royal Free Hospital Trust
generated by the participating GPs will be sent to
the research team. Letters relating to patients
referred to non-participating consultants will be
forwarded immediately to the routine outpatient
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hours by a medically qualified researcher who will
determine whether the letter suggests that the
patient satisfies the criteria for inclusion to the
study. Referral letters relating to patients who fail
to satisfy the inclusion criteria and those relating
to patients allocated to the control group will be
forwarded within 24 hours to the outpatients’
department to be dealt with in the routine way.
Consent
All those satisfying the criteria will be invited to
participate in the study. In line with the Zelen
method, consent will be actively sought only for
patients assigned to virtual outreach.4 The
research team will send these patients an
appointment letter including an explanation of
the nature of virtual outreach and an information
sheet, as well as a consent form which the patient
will be asked to complete and return to the
research team. While actively inviting the patients
to participate, the letter will explain their right to
seek further information or to refuse participation
and to undergo a conventional outpatient
consultation. Further information will be accessible
to patients, including an information telephone
line. The research team will send patients
allocated to the control arm of the study a
standard letter seeking their cooperation with the
research team in evaluating their experience of
routine outpatient referral. Ethical committee
approval for the study has been granted by the
Royal Free Ethics Committee.
The intervention group
Referral letters relating to patients allocated to
virtual outreach will be managed by the project
team, who will provide ready access to specialists
contracted to participate in the study. The project
team will operate an appointment system using the
hospital PAS computer. They will also use a range
of quality administrative systems for record keeping
and data collection relating to the consultations
and subsequent case management; these will ensure
that no letters are lost or delayed during their
passage through the project office. On selection of
a patient for intervention the project team will
identify a potential virtual outreach appointment
consistent with the availability of the specialist and
GP. Once the patient’s confirmation of availability
and willingness to attend has been obtained,
written confirmation of the arrangements will be
provided to all three parties. Each teleconsultation
will involve the following components:
  a scheduled videolink between the GP practice
and the identified consultant
  the patient and GP will be present together in
the GP’s surgery
  written clinical records will be kept by both GP
and consultant of the content and outcome of
the consultation.
If the virtual outreach consultation cannot be
satisfactorily performed because of technical
problems, the GP and consultant will be at liberty
to offer either a further virtual outreach
appointment or a conventional outpatients
appointment. If the patient fails to attend, s/he
will be offered one further appointment for a
virtual outreach consultation.
Evaluation
The evaluation has been designed to test the
following hypotheses:
When compared with conventional outpatients
virtual outreach consultations will:
  improve access for patients to specialist opinion
and reduce waiting times for appointments
  have a positive impact on patient satisfaction
and health status
  improve the quality of communication between
the patient, general practitioner and consultant
  reduce GP referrals to hospital and lead to
more appropriate referral patterns with
implications for workload
  reduce the number of medical interventions
and follow-up visits to routine outpatients
  result in greater professional satisfaction for
both GPs and consultants
  reduce the costs to the patients (in terms of
travelling costs and time) while not resulting in
any increased costs to the NHS.
Questionnaires
On entry to the study, patients recruited to either
virtual outreach or conventional outpatients will
receive an initial set of assessment questionnaires
to complete and return in a prepaid envelope to
the research team. The set will include a brief
questionnaire seeking routine demographic data
and a copy of the SF-12 to determine health
status.5–8 Additional information about the severity
of the patient’s condition will be sought from the
referring GP, who will be requested to complete a
Duke’s Severity of Illness (DUSOI) questionnaire.9
Questions to collect economic data will also be
included (see economic appraisal below).
Immediately following the consultation patients
will be sent copies of the Ware’s Visit Specific
Satisfaction Questionnaire (VSQ) to complete and
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questionnaires have been validated and widely
used in primary care settings.10 The questionnaire
seeks information on a range of domains relating
to the patient’s subjective experience of the
consultation.12 Subsequently, at three, six and
twelve months, patients will receive a copy of the
SF-12 to complete and return to the research team
in a prepaid envelope.
At 12 months from recruitment to the study the
research team also will undertake a retrospective
case-notes review of both the general practitioner’s
medical record and the hospital clinical record.
Relevant medical records will be scrutinised by a
researcher with clinical training and blind to the
allocation status of the patient. The review will
identify diagnostic tests, primarily laboratory tests
and radiological investigations, and also those in
receipt in either setting over the preceding 12
months of other investigations such as endoscopy
and MRI, as well as therapeutic interventions
(primarily medication but also injections, surgery
and other procedures).
GP outcomes
GP outcomes will be assessed in terms of changes
in referral behaviour in the first and last 3 months
of the study. The GPs’ referral rates to the
intervention (virtual outreach) specialities and
control (conventional outpatients) specialities will
be monitored throughout the study period, as will
the ‘case-mix’ of the patients referred to the
intervention and control specialities. ‘Case-mix’
will be measured using the DUSOI questionnaire
completed by the GPs for all the patients recruited
to the study. Although referral rates for any given
period should ideally be calculated in relation to
the number of individual patients seen in that
period, this is technically difficult to ascertain and
this study will use crude patient consultation rates
(calculated from the practices’ appointments and
home visits registers) as the denominator.
5. Project timetable
(1) Pilot RCT and expansion of the
service: June 1996–May 1997 
(12 months)
In the first phase of the study, the existing
teleconferencing network linking the Royal Free
with local practices will participate in a pilot study.
The objective of this phase is to test and refine all
the key components of the RCT, from the
randomisation process to outcome assessment and
follow-up. The pilot will further assist in the main
trial by providing more precise estimates of key
parameters, including patient recruitment rates
and values for outcomes in the intervention and
control groups. Formal training programmes will
be provided for the relevant clinical and
administrative staff in the Royal Free and in the
participating practices, together with user support
groups, equipment familiarisation and teaching
sessions.
(2) Main randomised controlled trial
and follow-up: June 1997–November
1998 (18 months)
The main study will commence once the pilot is
complete and all of the practices, participating
specialists and virtual outreach services are fully
operational. It is anticipated that the intervention
phase of the study will last for 6 months, with the
follow-up completed within 18 months.
Write-up and dissemination of results:
November 1998–July 1999 (9 months)
For details see Section 6. Methods of disseminating
results.
6. Methods of disseminating
results
The findings of the study will be made available as
soon as possible after completion of the study for
presentation at scientific and other relevant
meetings. Papers will be submitted for publication
in relevant peer-reviewed journals, and
subsequently in the more general medical and
popular press. The authors are actively
collaborating with the NHS Information
Management Group, the British Association of
Medical Managers, the National Association of
Health Authorities and Trusts, the Belfast
Telemedicine Institute and the Royal College of
General Practitioners, all of whom will be fully
consulted and briefed on the findings of 
the study.
7. Project people
Mr Robert Harrison will be piloting and modifying
as necessary the data collection forms, outcome
measures, monitoring and assessing relevant
literature, designing the process evaluation,
organising and supervising data analysis,
attending, supervising and presenting at
conferences, seminars and meetings during the
development recruitment and subsequent
dissemination of the research, preparing articles
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52for publications, assisting in the administration of
questionnaires and interviews, and data collection
including information for the economic appraisal.
Drs Will Clayton and Alasdair Unwin will be liaising,
recruiting, training and supporting the clinicians
involved with the project, liaising with the NHS
Trust and its staff, selecting outpatient referrals
according to the research criteria, analysis of
clinical records, assisting in the management of
the project, and general troubleshooting.
Ms Marcia Rigby will be designing, setting up and
running administrative systems for the smooth
running of the virtual outreach service, and for
general office procedures, developing contractual
arrangements with GPs and consultants,
maintaining task schedules and the project diary
for planning and timetabling the project, assisting
in the day-to-day work, supporting the virtual
outreach service and the research team, answering
the office phone and appointments hotline,
dealing with correspondence, and helping to
prepare reports, letters and publications.
Professor Paul Wallace retains overall responsibility
for the project and is particularly involved with
strategic and planning decisions.
Dr Jennifer Roberts will be designing the economic
appraisal, supervising the work of the BT
Research Fellow, Hamnet Patel, and undertaking
the analysis of the economic data.
Mr Paul Gamer represents BT’s interest in the
project, which is to fund the technology and the
economic appraisal.
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The Royal Free Hospital School of Medicine
THE UNIVERSITY OF LONDON
0207 435 1368
OUTPATIENTS BY TELEVISION
Dear Patient,
An outpatient appointment has been made for you to see Mr Quinsy ENT Consultant on Friday 18
October 1996 at 9.00am. This appointment will take place at Dr Finlay’s surgery at the Hollywood
Medical Centre. If possible could you please arrive at Dr Finlay’s surgery 15 minutes before your
appointment time. If you cannot attend this consultation, please inform your practice as soon as possible.
You and your doctor will then be able to discuss your problem together with the consultant at the Royal Free via a
television link-up. This is called the Teleclinic and is part of a research project at the hospital. The use of the Teleclinic
means that we have been able to offer you an appointment without you having to travel to the hospital. We would like
you to read the enclosed information sheet and hope that you will feel you want to use this new facility.
If you have any doubts you may choose to have a normal appointment at the hospital in due course. This
will not affect your care in any way. If you decide now to help with this research but later want to
withdraw, you are free to do so, just let me know at the above telephone number.
Enclosed is a questionnaire and consent form, which should be completed and returned to the Teleclinic
office in the enclosed prepaid envelope before your appointment.
I will telephone you to confirm your Teleclinic appointment but in the meantime, if you have any
questions, please do not hesitate to contact me at the Project Office on the number above.
Yours sincerely
Marcia Rigby (Project Administrator)
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OUTPATIENTS by TELEVISION
Your name
Place of consultation
Your doctor
Date
Please read this form carefully. If anything is unclear, or if you wish to know more, please contact 
Ms Marcia Rigby on: 0207-435-1368.
I am the: patient/parent/guardian (delete as necessary)
I have received and read the information sheet YES/NO
I agree to take part in a Teleconsultation YES/NO
I understand that this is part of a scientific evaluation of Teleconferenced medical consultations
YES/NO
I agree to my consultation being video recorded and used solely for research YES/NO
N.B. If you agree to the consultation being recorded, we will re-confirm this with you by post after the consultation.
Signed………………………………… DATE / /
MANY THANKS – YOUR HELP WITH THIS RESEARCH IS APPRECIATED
Please return to:
Marcia Rigby
Department of Primary Care & Population Sciences
Upper 3rd Floor, Rowland Hill Street
LONDON NW3 2PF
Tel. 0207-435-1368
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Outpatients by television
We have asked you to take part in research about the use of some new technology. Teleconferencing is providing a way
of getting a hospital doctor’s opinion while sitting with your GP in their surgery. This information sheet is to help you
decide if you want to have a teleconsultation. If you do not want one it will not affect your care in any way.
What is a teleconsultation?
Your doctor can now phone the hospital and get the specialist on his computer screen. It is like bringing
the hospital doctor to the surgery but without him actually being there. They can see and hear you and
you can see and hear them. This means that you may not need to go to the hospital outpatients to see
the specialist.
We have found that the hospital doctors can often gather all the information they need using
teleconferencing. When they cannot, they ask your GP to examine you.
Teleconsulting is new and exciting. We believe it can provide a better service, however we must examine it
scientifically. We will be seeing if it can improve the result of consultations.
What will happen after the consultation?
We will keep notes of the sort of cases that use the system. This information will be kept safe and
confidential, just like your doctor’s records. The results of the work will be published in medical journals
but none of your personal details will be published.
If you give permission, some of the consultations will be recorded on video. This is so that we can study
the consultation in detail. These recordings may also be used for teaching. They will not be used for any
other purpose.
What will taking part in the research involve?
We will send you 4 short questionnaires to gather basic information on you and your feelings about the
consultation as well as how you are. One will be before and one after your consultation, one 3 months
later and a final one at 6 months. An addressed, reply-paid envelope will be provided for you to return
them to us.
Who is paying for the study?
The research is being paid for by the NHS. This covers the salaries and expenses of the research project.
BT are paying for the teleconferencing equipment.
How confidential is it?
We use special high-capacity phone lines to transmit the sound and images between the hospital and GP’s
surgery. These are safer and more confidential than the phone you use to phone your doctor – there is
almost no chance of getting a ‘crossed line’.
Changing your mind
You can end your involvement at any time during the consultation or afterwards. To withdraw either write
to the project administrator, Marcia Rigby, or telephone the project office on 0207 435 1368. Withdrawal
will not alter your care in any way.
IF THERE IS ANYTHING ELSE YOU NEED TO KNOW, PLEASE ASK.
THE PROJECT OFFICE NUMBER IS 0207 435 1368.
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56Specialities & consultants at the Royal Free Hospital
Availability guide
Prof Carol Black Monday 8.45
Dr Gareth Beynon
Dr Pierre Bouloux Tuesday 8.45, Thursday 1.30
Ms Deborah Eastwood Monday 8.45
Dr Owen Epstein Tuesday 9.30
Dr David Flynn
Mr Nick Goddard Tuesday 8.45
Dr Alison Jones
Mr Amir Kaisary Tuesday 14.00
Dr Ben Lloyd Monday 8.45
Mr Robert Morgan Monday 9.30
Mr Robert Quiney Friday 9.00
Dr van Someron
Prof Brent Taylor
Dr Anthony White
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Outpatients by television – a trial
As part of this practice’s commitment to medical
research and education we have decided to take
part in a trial to look at a new way in which you
might be able to get a hospital doctor’s advice.
This sheet will give you some information about a
new technology, its purpose and how a trial of its
use might affect you.
Teleconferenced outpatient
consultations (teleclinics)
It is now possible, using computers and video
cameras, to send and receive pictures down the
telephone network. We have installed a trial
system in the practice so that your doctor can
phone the hospital and get a specialist on a
computer screen. It is like bringing the hospital
doctor to the surgery but without him actually
being there. They can see and hear you and you
can see and hear them. This means that you may
be able to have a joint consultation with your
doctor and the specialist in this surgery. The
hospital specialists will not be able to examine 
you so they may ask your doctor to help or ask
you to go up to the hospital outpatients at a later
date.
What is the purpose of the trial?
This technology is new and exciting, but is it any
use? This is the question we want to look at with
the doctors at the Royal Free Hospital. We will be
seeing which specialities and which sort of
problems it most suits.
How might the trial affect you?
Because we are helping in this trial, if your doctor
refers you to a hospital specialist, some of you will
be offered a ‘teleclinic’ appointment. The selection
will be made by doctors at the hospital based on
your doctor’s letter.
What will happen if I am selected?
If you are selected for a ‘teleclinic’ appointment
you will be contacted by the trial team and offered
an appointment time for you to come to this
surgery. After the consultation you will be asked to
complete a short questionnaire. A small number of
people will also be interviewed by a researcher. If
you do not want to be part of this trial then please
let us know, it will not affect your care in any way.
What will happen to the results?
Notes will be kept of the sort of cases that use the
system. This information will be kept safe and
confidential, just like your records here. The
results of the trial will be published in medical
journals but none of your personal details will be
published. If you agree, some of the consultations
will be video recorded. This is so that we can study
the consultation in detail.
How confidential is it?
We use special high-capacity phone lines. These
are as confidential as the phone you use to phone
your doctor, probably more so. There may be
other people at the hospital end but out of your
sight. They will be introduced. You will be asked if
they can stay. The sort of people who might be in
the room with the hospital doctor are: other
doctors, medical students or a member of the
research team.
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Appendix 2
Patient information leaflet and consent formInformation sheet
Outpatients by television
We have asked you to take part in research about the use of some new technology. Teleconferencing is providing a way
of getting a hospital doctor’s opinion while sitting with your GP in their surgery. This information sheet is to help you
decide if you want to have a teleconsultation. If you do not want one it will not affect your care in any way.
What is a teleconsultation?
Your doctor can now phone the hospital and get the specialist on his computer screen. It is like bringing
the hospital doctor to the surgery but without him actually being there. They can see and hear you and
you can see and hear them. This means that you may not need to go to the hospital outpatients to see
the specialist.
We have found that the hospital doctors can often gather all the information they need using
teleconferencing. When they cannot, they ask your GP to examine you.
Teleconsulting is new and exciting. We believe it can provide a better service, however we must examine it
scientifically. We will be seeing if it can improve the result of consultations.
What will happen after the consultation?
We will keep notes of the sort of cases that use the system. This information will be kept safe and
confidential, just like your doctor’s records. The results of the work will be published in medical journals
but none of your personal details will be published.
If you give permission, some of the consultations will be recorded on video. This is so that we can study
the consultation in detail. These recordings may also be used for teaching. They will not be used for any
other purpose.
What will taking part in the research involve?
We will send you 4 short questionnaires to gather basic information on you and your feelings about the
consultation as well as how you are. One will be before and one after your consultation, one 3 months
later and a final one at 6 months. An addressed, reply-paid envelope will be provided for you to return
them to us.
Who is paying for the study?
The research is being paid for by the NHS. This covers the salaries and expenses of the research project.
BT are paying for the teleconferencing equipment.
How confidential is it?
We use special high-capacity phone lines to transmit the sound and images between the hospital and GP’s
surgery. These are safer and more confidential than the phone you use to phone your doctor – there is
almost no chance of getting a ‘crossed line’.
Changing your mind:
You can end your involvement at any time during the consultation or afterwards. To withdraw either write
to the project administrator, Marcia Rigby, or telephone the project office on 0207 435 1368. Withdrawal
will not alter your care in any way.
IF THERE IS ANYTHING ELSE YOU NEED TO KNOW, PLEASE ASK.
THE PROJECT OFFICE NUMBER IS 0207 435 1368.
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OUTPATIENTS by TELEVISION
Your name 
Place of consultation
Your doctor
Date
Please read this form carefully. If anything is unclear, or if you wish to know more, please contact 
Ms Marcia Rigby on: 0207-435-1368.
I am the: patient/parent/guardian (delete as necessary)
I have received and read the information sheet YES/NO
I agree to take part in a Teleconsultation YES/NO
I understand that this is part of a scientific evaluation of Teleconferenced medical consultations
YES/NO
I agree to my consultation being video recorded and used solely for research YES/NO
N.B. If you agree to the consultation being recorded, we will re-confirm this with you by post after the consultation.
Signed………………………………… DATE / /
MANY THANKS – YOUR HELP WITH THIS RESEARCH IS APPRECIATED
Please return to:
Marcia Rigby
Department of Primary Care & Population Sciences
Upper 3rd Floor, Rowland Hill Street
LONDON NW3 2PF
Tel. 0207-435-1368
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Appendix 3
Duke Severity of Illness (DUSOI) questionnaireDUSOI Cover Sheet
GPs: Please fill in patient’s details below
Patient Name:
(BLOCK CAPITALS PLEASE)
DOB:
Address:
(BLOCK CAPITALS PLEASE)
Telephone Numbers
Day
Home
Mobile
Coding Criteria – Use for guidance when filling in the form:
None Questionable Mild Moderate Major
Symptoms (past week) 0 1 2 3 4
Complications (past week) 0 1 2 3 4
Disability Threat to Life
None Questionable Mild Moderate Major
Prognosis
(6 months without treatment) 0 1 2 3 4
Need for treatment Expected response to treatment
Treatability No Questionable Good Questionable Poor
(if yes)
0 123 4
Copyright © 1990 Department of Community and Family Medicine, Duke University Medical Center,
Durham, NC, USA
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Strictly confidential
Please answer each question by placing a cross in the appropriate box(es), 
see below for an example .... 
Describe each health problem and indicate the relevant severity scores, cross one box between 0–4 for
each item.
Health Problems Symptoms Complications Prognosis Treatability
1. 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
2.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
3.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
4.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
5.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
6.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
7.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
8.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
9.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
10.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
11.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
12.  0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
✕
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THIS SECTION IS FOR OFFICE USE ONLY
(a) Patient Identifier
(b) TELECONSULT
OUTPATIENT
(c) LONDON
SHREWSBURY 
(d) SPECIALITY 0 1 2 3 4 5 6 7 8 9 1 0
10
1
(e) PRACTICE CODE  0 1 2 3 4 5 6 7 8 9 1 0
10
1
(f) GP  CODE 0 1 2 3 4 5 6 7 8 9 1 0
10
1
Virtual Outreach Project
Patient Questionnaire 1
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
Please ensure this questionnaire is completed only by the patient to whom the letter was sent. If this is
not possible this should be filled in with a relative or carer.
Please answer all the questions in the correct order by placing a cross in the appropriate box(es) like 
this ……  Begin with Q2 at the top of the next page.
Thank you for your help.
We would like to start with a little basic information about yourself.
✕
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Appendix 4
Patient questionnaire 1 (Adult and Child)Q2 What is your date of birth?
(start with the day, month and then year)
D DM M YYYY
Q3 What is your sex?
(place a cross in one box only)
Male Female
Q4 Is there a car or van that you or someone in the home can use?
(place a cross in one box only)
Yes No
Q5 What is your marital status?
(place a cross in one box only)
Married Co-habiting
Single (never married) Divorced or separated
Widowed
Q6 Are you still in full time education?
Yes No
If no, at what age did you leave?
(write the correct age in the box)
Q7 Which of the following do you think describes you?
(place a cross in one box only)
White Black Caribbean Black African
Black Other Indian Pakistani
Bangladeshi Chinese Other Asian
Other ethnic groups (please write in box below)
Q8 At present are you.... 
(place a cross in one box only)
At school or a student Employed full time
Employed part time Unemployed seeking work
Unemployed not seeking work Retired
Other (please write in box below)
Now we want to ask you about your health in the last 4 weeks. This information will help keep track of how you feel
and how well you are able to do your usual activities. Please answer every question by marking one box. If you are
unsure about how to answer, please give the best answer you can.
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(Please put a cross in one box)
Excellent Very good Good Fair Poor
Q10 The following questions are about activities you might do during a typical day. Does your health
now limit you in these activities? If so, how much?
(Please put a cross in one box on each line)
Moderate activities, lifting or carrying shopping, pushing a vacuum cleaner or playing golf
Yes, limited a lot Yes, limited a little No, not limited at all
Climbing several flights of stairs
Yes, limited a lot Yes, limited a little No, not limited at all
Q11 During the past 4 weeks, have you had any of the following problems with your work or other
regular daily activities as a result of your physical health? (Please put a cross in one box on each line)
Accomplished less than you would like Yes No
Were limited in the kind of work or other activities Yes No
Q12 During the past 4 weeks, have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
(Please put a cross in one box on each line)
Accomplished less than you would like Yes No
Didn’t do work or other activities as carefully as usual Yes No
Q13 During the past 4 weeks, how much did pain interfere with your normal work (including both work
outside the home and housework)? (Please put a cross in one box)
Not at all A little bit Moderately Quite a bit
Extremely
The next questions are about how you feel and how things have been with you during the past 4 weeks. For each
question, please give the one answer that comes closest to the way you have been feeling.
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All of  Most of  A good bit  Some of  A little of  None of 
the time the time of the time the time the time the time
Have you felt calm and 
peaceful?
Did you have a lot of energy?
Have you felt downhearted and 
low?
Q15 During the past 4 weeks, how much of the time has your physical health or emotional problems
interfered with your social activities (like visiting friends and relatives)?
(Please put a cross in one box) 
All of the time Most of the time Some of the time
A little of the time None of the time
Please make any additional comments below ....
This questionnaire includes the SF-12™ Health Survey, item numbers 10 to 16 in this questionnaire,
reproduced with permission of the Medical Outcomes Trust, Copyright © 1994 The Health Institute;
New England Medical Center.
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THIS SECTION IS FOR OFFICE USE ONLY
(a) Patient Identifier
(b) TELECONSULT
OUTPATIENT
(c) LONDON
SHREWSBURY 
(d) SPECIALITY 0 1 2 3 4 5 6 7 8 9 1 0
10
1
(e) PRACTICE CODE  0 1 2 3 4 5 6 7 8 9 1 0
10
1
(f) GP  CODE 0 1 2 3 4 5 6 7 8 9 1 0
10
1
Virtual Outreach Project
Children’s Questionnaire 1
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
This questionnaire is for patients under 16 years old and should be completed by a parent or guardian.
For children between 5 and 16 years old please complete all questions. For children under 5 years
complete questions 2 to 10 only.
Please answer all the questions in the correct order by placing a cross in the appropriate box(es) like 
this ……  Begin with Q2 at the top of the next page.
We would like to start with a little basic information.
✕
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(start with the day, month and then year)
D DM M YYYY
Q3 What is your child’s sex?
(place a cross in one box only)
Male Female
Q4 Which of the following best describes your relationship with your child?
(place a cross in one box only)
Biological parent Step parent Foster parent
Adoptive parent Guardian
Other (please explain in the box below)
Q5 Is there a car or van that you or someone in the home can use?
Yes No
Q6 What is your marital status?
(place a cross in one box only)
Married Co-habiting Single (never married)
Divorced or separated Widowed
Q7 At present are you.... 
(place a cross in one box only)
At school or a student Employed full time
Employed part time Unemployed seeking work
Unemployed not seeking work Retired
Other (please write in box below)
Q8 Are you still in full time education?
Yes No If no, at what age did you leave?
(write the correct age in the box)
Q9 Which of the following do you think describes you?
(place a cross in one box only)
White Black Caribbean Black African
Black Other Indian Pakistani
Bangladeshi Chinese Other Asian
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Q10 Is your child less than 5 years old?
Yes No
If ‘yes’ terminate the question here.
This section asks about your child’s health and well being. Your individual answers will not be shared with anyone.
Certain questions may look alike but each one is different. Some questions ask about problems your child may not have.
That’s great, but it’s important for us to know. Please answer each question. There are no right or wrong answers. If
you are unsure how to answer a question, please give the best answer you can and make a comment in the margin. All
comments will be read, so please feel free to make as many as you wish.
Q11 In general would you say your child’s health is:
(Please put a cross in one box)
Excellent Very good Good Fair Poor
Q12 During the past four weeks, has your child been limited in any of the following activities due to
health problems?
(place a cross in one box on each line)
Yes, limited  Yes, limited  Yes, limited  No, not 
a lot some a little limited
Doing things that take a lot of energy, such as 
playing soccer or running?
Doing things that take some energy, such as riding 
a bike or skating?
Bending, lifting or stooping?
Q13 During the past four weeks, has your child been limited in the AMOUNT of time he/she could
spend on schoolwork or activities with friends due to EMOTIONAL difficulties or problems with his/her
BEHAVIOUR? (place a cross in one box only)
Yes, limited a lot Yes, limited some Yes, limited a little
No, not limited
Q14 During the past four weeks, has your child been limited in the KIND of schoolwork or activities
he/she could do with friends due to problems with his/her PHYSICAL health?
(place a cross in one box only)
Yes, limited a lot Yes, limited some Yes, limited a little
No, not limited
Q15 During the past four weeks, how often has your child had bodily pain or discomfort?
None of  Once or  A few times Fairly often Very often Every or 
the time twice almost every day
Below is a list of items that describe children’s behaviour or problems they sometimes have.
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(please place a cross in one box on each line)
Very often Fairly often Sometimes Almost  Never
never
Argued a lot 
Had difficulty concentrating or paying 
attention
Lied or cheated 
Q17 Compared to other children your child’s age, in general would you say his/her behaviour is:
Excellent Very good Good Fair Poor
Q18 During the past four weeks how much of the time do you think your child:
(please place a cross in one box on each line)
All of  Most of  Some of  A little of  None of 
the time the time the time the time the time
Felt lonely?
Acted nervous?
Acted bothered or upset?
The following ask about your child’s satisfaction with self, school and others. It may be helpful if you keep in mind how
other children your child’s age might feel about these areas.
Q19 During the past four weeks, how satisfied do you think your child has felt about:
(please place a cross in one box on each line)
Very Somewhat  Neither  satisfied  Somewhat  Very 
satisfied satisfied or dissatisfied dissatisfied dissatisfied
his/her school ability? 
his/her friendships? 
his/her life overall?
Q20 How true or false is the statement for your child? (please place a cross in one box on each line)
Definitely  Mostly Don’t Mostly  Definitely 
true true know false false
My child seems to be less healthy than other 
children I know
My child has never been seriously ill 
I worry about my child’s health more than other 
people worry about their children’s
Q21 Compared to one year ago, how would you rate your child’s health?
Much better now than 1 year ago
Somewhat better than 1 year ago
About the same now as 1 year ago
Somewhat worse now than 1 year ago
Much worse now than 1 year ago
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YOU? (please place a cross in one box on each line)
None at all A little bit Some Quite a bit A lot
Your child’s physical health 
Your child’s emotional well being or behaviour
Q23 During the past 4 weeks, were you LIMITED in the amount of time YOU have for your own needs
because of: (please place a cross in one box on each line)
None at all A little bit Some Quite a bit A lot
Your child’s physical health?
Your child’s emotional well being or behaviour?
Q24 During the past 4 weeks, how often has your child’s health or behaviour (please place a cross in one box
on each line)
Very often Fairly often Sometimes Almost  Never
never
Limited the types of activities you could 
do as a family?
Interrupted various everyday family 
activities (eating meals, watching TV)?
Q25 Sometimes families may have difficulty getting along with one another. They do not always agree
and they may get angry. In general, how often would you rate your family’s ability to get along with one
another?
Excellent Very good Good Fair Poor
Q26 Have you ever been told by a teacher, school official, doctor or other health professional that your
child has any of the following conditions? (please place a cross in one box on each line)
Yes No
Anxiety problems
Asthma
Attentional problems
Behavioural problems
Chronic allergies or sinus trouble
Chronic orthopaedic, bone or joint problems
Chronic respiratory, lung or breathing trouble (NOT ASTHMA)
Chronic rheumatic disease
Depression
Developmental delay or learning difficulties
Diabetes
Epilepsy (seizure disorder)
Hearing impairment or deafness
Learning problems
Sleep disturbance
Speech problems
Vision problems
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Yes No
(Please describe in box below)
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Appendix 5
Patient questionnaire 2 (Adult and Child – standard 
outpatient and teleconsultation)Patient Identifier
Virtual Outreach Project
Patient Questionnaire 2 (Adult – outpatient)
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
Please ensure this questionnaire is completed only by the patient to whom the letter was sent. If this is
not possible this should be filled in with a relative or carer.
When answering these questions you will be asked to either place a cross in a box like this  or enter
numbers in the boxes.
Begin with Q2 below 
Q2 Please enter today’s date below 
for example 1st March 1999 would be 01/03/1999
D DM M YYYY
Now, we would like to ask some questions about the consultation with the hospital specialist 
Q3 (a) How would you rate each of the following? (b) place a cross in one box on each line
Excellent Very good Good Fair Poor
1. how long you waited to get an appointment
2. convenience of the location of the hospital/clinic
3. getting through to the hospital, surgery or project 
office by phone If not applicable place a cross here
4. length of time waiting at the hospital/clinic
5. time spent in the consultation with the doctor 
you saw
6. ease of making/changing an appointment time 
If not applicable place a cross here
7. convenience of day and/or time of appointment 
with the specialist
8. personal manner (courtesy, respect, sensitivity, 
friendliness) of the reception staff
9. waiting area and facilities 
10. attention given to what you had to say
11. explanation of what was done for you
12. the technical skills (the thoroughness, carefulness, 
competence) of the doctor you saw
13. the personal manner (courtesy, respect, sensitivity, 
friendliness) of the doctor you saw
14. the visit overall 
✕
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each line
Much better Better Same or less Not applicable
Able to cope with life
Able to understand your illness
Able to cope with your illness
Able to keep yourself healthy
Much more More Same or less Not applicable
Confident about your health
Able to help yourself
Do you have any additional comments? please use the space below
We would now like to ask you some questions about the costs of attending your outpatient’s appointment
Q5 Thinking about your recent health problem and your referral to see the hospital specialist, did you
have to go back and see your GP for the same health problem while you were waiting for your
appointment?
Yes No
If yes, please tell us how many times
Q6 Has your GP visited you at home about your health problem, since the referral?
Yes No
If yes, please tell us how many times
Q7 Were you visited by someone from any other service about your health problem? (for example by the
district nurse)
Yes No
If yes, please specify in Q8
If no, carry on to Q9
Q8 Were you visited by ...
District nurse?  Yes Number of times
Practice nurse? Yes Number of times
Home care? Yes Number of times
Meals on wheels? Yes Number of times
Other please state in boxes below
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2. other Yes Number of times
3. other Yes Number of times
Q9 Did you, or anyone accompanying you to the consultation with the hospital specialist, incur any
travel costs?
write to the nearest £ what you thought your costs were in the boxes below
none £ taxi £ 
public transport £  other (specify below)£  
private car £ 
Q10 How long does it take to visit the hospital and return home again?
place a cross in one box only
up to 30 minutes 30 minutes to 1 hour
l to 2 hours 3 to 4 hours 
5 to 6 hours longer than 6 hours 
Q11 Since being referred to the specialist for your health problem did you have to buy anything special?
(e.g. clothing, foods, dressings)
Yes No
How much to the nearest pound did you have to spend? £ 
What did you buy?
Q12 Did you, or anyone accompanying you, have to take time off work?
Yes If Yes, please complete Q13
No If No, please go to Q14
Q13 Did either you or your companion lose any pay?
Yes If yes fill in how much below to the nearest £, if no carry on to the next question
No
You £ 
Your companion £ 
Q14 Did you, or anyone accompanying you, take annual leave in order to attend your appointment with
the specialist?
you your companion
Yes
No
Q15 Did you, or anyone accompanying you, have to miss any activity or routine responsibility, other than
work, in order to attend your appointment?
Yes If ‘Yes’, please cross the appropriate box below
No If ‘No’ go to Ql6
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a social occasion or pastime
picking up or dropping off children at school
other
Please specify other in box
Q16 If you, or a person attending with you, had to make special arrangements for childcare did it cost
you anything?
Yes please tell us to the nearest how much in the boxes £ 
No If you answered No please go to the next question
Q17 As a result of seeing the specialist, were you? Please place a cross in all boxes that apply
given a prescription
put on a waiting list for surgery
discharged or told the specialist did not need to see you again
given a further appointment to see the specialist
sent for complementary medicine (e.g. osteopathy, acupuncture)
sent for an x-ray, scan or other test or examination, given injections, given bandages
sent for therapy (e.g. physiotherapy)
other please specify other in box below
Q18 If you have any comments about the consultation, write them in the box below continue overleaf if
required
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Patient Questionnaire 2 (Child – outpatient)
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
This questionnaire is for patients under 16 years old and should be completed by a parent or guardian.
When answering these questions you will be asked to either place a cross in a box like this  or enter
numbers in the boxes.
Begin with Q2 below 
Q2 Please enter today’s date below 
for example 1st March 1999 would be 01/03/1999
D DM M YYYY
Now, we would like to ask some questions about the consultation with the hospital specialist 
Q3 (a) How would you rate each of the following? (b) place a cross in one box on each line
Excellent Very good Good Fair Poor
1. how long you waited to get an appointment
2. convenience of the location of the hospital/clinic
3. getting through to the hospital, surgery or project 
office by phone If not applicable place a cross here
4. length of time waiting at the hospital/clinic
5. time spent in the consultation with the doctor 
you saw
6. ease of making/changing an appointment time 
If not applicable place a cross here
7. convenience of day and/or time of appointment with 
the specialist
8. personal manner (courtesy, respect, sensitivity, 
friendliness) of the reception staff
9. waiting area and facilities 
10. attention given to what you had to say
11. explanation of what was done for you
12. the technical skills (the thoroughness, carefulness, 
competence) of the doctor you saw
13. the personal manner (courtesy, respect, sensitivity, 
friendliness) of the doctor you saw
14. the visit overall 
✕
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each line
Much better Better Same or less Not applicable
Able to cope with life
Able to understand your child’s illness
Able to cope with your child’s illness
Able to keep your child healthy
Much more More Same or less Not applicable
Confident about your child’s health
Able to help your child
Do you have any additional comments? please use the space below
We would now like to ask you some questions about the costs of attending your outpatient’s appointment
Q5 Thinking about your child’s recent health problem and your referral to see the hospital specialist,
did you have to go back and see your GP for the same health problem while you were waiting for your
child’s appointment?
Yes No
If yes, please tell us how many times
Q6 Has your GP visited your child at home about your health problem, since the referral?
Yes No
If yes, please tell us how many times
Q7 Were you visited by someone from any other service about your child’s health problem? (for example
by the district nurse)
Yes No
If yes, please specify in Q8
If no, carry on to Q9
Q8 Were you visited by ...
District nurse?  Yes Number of times
Practice nurse? Yes Number of times
Home care? Yes Number of times
Meals on wheels? Yes Number of times
Other please state in boxes below
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2. other Yes Number of times
3. other Yes Number of times
Q9 Did you, or anyone accompanying you to the consultation with the hospital specialist, incur any
travel costs?
write to the nearest £ what you thought your costs were in the boxes below
none £ taxi £ 
public transport £  other (specify below)£  
private car £ 
Q10 How long does it take to visit the hospital and return home again?
place a cross in one box only
up to 30 minutes 30 minutes to 1 hour
l to 2 hours 3 to 4 hours 
5 to 6 hours longer than 6 hours 
Q11 Since being referred to the specialist for your child’s health problem did you have to buy anything
special? (e.g. clothing, foods, dressings)
Yes No
How much to the nearest pound did you have to spend? £ 
What did you buy?
Q12 Did you, or anyone accompanying you, have to take time off work?
Yes If Yes, please complete Q13
No If No, please go to Q14
Q13 Did either you or your companion lose any pay?
Yes If yes fill in how much below to the nearest £, if no carry on to the next question
No
You £ 
Your companion £ 
Q14 Did you, or anyone accompanying you, take annual leave in order to attend your child’s
appointment with the specialist?
you your companion
Yes
No
Q15 Did you, or anyone accompanying you, have to miss any activity or routine responsibility, other than
work, in order to attend your child’s appointment?
Yes If ‘Yes’, please cross the appropriate box below
No If ‘No’ go to Ql6
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a social occasion or pastime
picking up or dropping off children at school
other
Please specify other in box
Q16 If you, or a person attending with you, had to make special arrangements for childcare did it cost
you anything?
Yes please tell us to the nearest how much in the boxes £ 
No If you answered No please go to the next question
Q17 As a result of your child seeing the specialist, was your child Please place a cross in all boxes that apply
given a prescription
put on a waiting list for surgery
discharged or told the specialist did not need to see you again
given a further appointment to see the specialist
sent for complementary medicine (e.g. osteopathy, acupuncture)
sent for an x-ray, scan or other test or examination, given injections, given bandages
sent for therapy (e.g. physiotherapy)
other please specify other in box below
Q18 If you have any comments about the consultation, write them in the box below continue overleaf if
required
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Patient Questionnaire 2 (Adult – teleconsultation)
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
Please ensure this questionnaire is completed only by the patient to whom the letter was sent. If this is
not possible this should be filled in with a relative or carer.
When answering these questions you will be asked to either place a cross in a box like this  or enter
numbers in the boxes.
Begin with Q2 below 
Q2 Please enter today’s date below 
for example 1st March 1999 would be 01/03/1999
D DM M YYYY
Now, we would like to ask some questions about the teleconsultation at your GP’s surgery …
Q3 (a) How would you rate each of the following? (b) place a cross in one box on each line
Excellent Very good Good Fair Poor
1. how long you waited to get an appointment
2. convenience of the location of the hospital/clinic
3. getting through to the hospital, surgery or project 
office by phone If not applicable place a cross here
4. length of time waiting at the hospital/clinic
5. time spent in the consultation with the doctor you 
saw
6. ease of making/changing an appointment time 
If not applicable place a cross here
7. convenience of day and/or time of appointment 
with the specialist
8. personal manner (courtesy, respect, sensitivity, 
friendliness) of the reception staff
9. waiting area and facilities 
10. attention given to what you had to say
11. explanation of what was done for you
12. the technical skills (the thoroughness, carefulness, 
competence) of the doctor you saw
13. the personal manner (courtesy, respect, sensitivity, 
friendliness) of the doctor you saw
14. the visit overall 
✕
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each line
Much better Better Same or less Not applicable
Able to cope with life
Able to understand your illness
Able to cope with your illness
Able to keep yourself healthy
Much more More Same or less Not applicable
Confident about your health
Able to help yourself
Do you have any additional comments? please use the space below
We would now like to ask you some questions about the costs of attending the GP’s surgery for your
teleconsultation with the hospital specialist …
Q5 Thinking about your recent health problem and your referral to see the hospital specialist, did you
have to go back and see your GP for the same health problem while you were waiting for your
appointment?
Yes No
If yes, please tell us how many times
Q6 Has your GP visited you at home about your health problem, since the referral?
Yes No
If yes, please tell us how many times
Q7 Were you visited by someone from any other service about your health problem? (for example by the
district nurse)
Yes No
If yes, please specify in Q8
If no, carry on to Q9
Q8 Were you visited by …
District nurse?  Yes Number of times
Practice nurse? Yes Number of times
Home care? Yes Number of times
Meals on wheels? Yes Number of times
Other please state in boxes below
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2. other Yes Number of times
3. other Yes Number of times
Q9 Did you, or anyone accompanying you to the GP’s surgery, incur any travel costs?
write to the nearest £ what you thought your costs were in the boxes below
none £ taxi £ 
public transport £  other (specify below)£  
private car £ 
Q10 How long does it take to visit the surgery and return home again?
place a cross in one box only
up to 30 minutes 30 minutes to 1 hour
l to 2 hours 3 to 4 hours 
5 to 6 hours longer than 6 hours 
Q11 Since being referred to the specialist for your health problem, did you have to buy anything special?
(e.g. clothing, foods, dressings)
Yes No
How much to the nearest pound did you have to spend? £ 
What did you buy?
Q12 Did you, or anyone accompanying you, have to take time off work?
Yes If Yes, please complete Q13
No If No, please go to Q14
Q13 Did either you or your companion lose any pay?
Yes If yes fill in how much below to the nearest £, if no carry on to the next question
No
You £ 
Your companion £ 
Q14 Did you, or anyone accompanying you, take annual leave in order to attend your appointment with
the specialist?
you your companion
Yes
No
Q15 Did you, or anyone accompanying you, have to miss any activity or routine responsibility, other than
work, in order to attend your appointment?
Yes If ‘Yes’, please cross the appropriate box below
No If ‘No’ go to Ql6
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a social occasion or pastime
picking up or dropping off children at school
other
Please specify other in box
Q16 If you, or a person attending with you, had to make special arrangements for childcare did it cost
you anything?
Yes please tell us to the nearest how much in the boxes £ 
No If you answered No please go to the next question
Q17 As a result of seeing the specialist, were you Please place a cross in all boxes that apply
given a prescription
put on a waiting list for surgery
discharged or told the specialist did not need to see you again
given a further appointment to see the specialist
sent for complementary medicine (e.g. osteopathy, acupuncture)
sent for an x-ray, scan or other test or examination, given injections, given bandages
sent for therapy (e.g. physiotherapy)
other please specify other in box below
Q18 If you have any comments about the consultation, write them in the box below continue overleaf if
required
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Patient Questionnaire 2 (Child – teleconsultation)
Please do not write your name anywhere on this questionnaire. All information provided is strictly
confidential.
This questionnaire is for patients under 16 years old and should be completed by a parent or guardian.
When answering these questions you will be asked to either place a cross in a box like this  or enter
numbers in the boxes.
Begin with Q2 below 
Q2 Please enter today’s date below 
for example 1st March 1999 would be 01/03/1999
D DM M YYYY
Now, we would like to ask some questions about the teleconsultation at your GP’s surgery …
Q3 (a) How would you rate each of the following? (b) place a cross in one box on each line
Excellent Very good Good Fair Poor
1. how long you waited to get an appointment
2. convenience of the location of the hospital/clinic
3. getting through to the hospital, surgery or project 
office by phone If not applicable place a cross here
4. length of time waiting at the hospital/clinic
5. time spent in the consultation with the doctor you 
saw
6. ease of making/changing an appointment time 
If not applicable place a cross here
7. convenience of day and/or time of appointment 
with the specialist
8. personal manner (courtesy, respect, sensitivity, 
friendliness) of the reception staff
9. waiting area and facilities 
10. attention given to what you had to say
11. explanation of what was done for you
12. the technical skills (the thoroughness, carefulness, 
competence) of the doctor you saw
13. the personal manner (courtesy, respect, sensitivity, 
friendliness) of the doctor you saw
14. the visit overall 
✕
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each line
Much better Better Same or less Not applicable
Able to cope with life
Able to understand your child’s illness
Able to cope with your child’s illness
Able to keep your child healthy
Much more More Same or less Not applicable
Confident about your child’s health
Able to help your child
Do you have any additional comments? please use the space below
We would now like to ask you some questions about the costs of attending the GP’s surgery for your
teleconsultation with the hospital specialist.
Q5 Thinking about your child’s recent health problem and your referral to see the hospital specialist,
did you have to go back and see your GP for the same health problem while you were waiting for your
child’s appointment?
Yes No
If yes, please tell us how many times
Q6 Has your GP visited your child at home about your health problem, since the referral?
Yes No
If yes, please tell us how many times
Q7 Were you visited by someone from any other service about your child’s health problem? (for example
by the district nurse)
Yes No
If yes, please specify in Q8
If no, carry on to Q9
Q8 Were you visited by …
District nurse?  Yes Number of times
Practice nurse? Yes Number of times
Home care? Yes Number of times
Meals on wheels? Yes Number of times
Other please state in boxes below
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2. other Yes Number of times
3. other Yes Number of times
Q9 Did you, or anyone accompanying you to the GP’s surgery, incur any travel costs?
write to the nearest £ what you thought your costs were in the boxes below
none £ taxi £ 
public transport £  other (specify below) £ 
private car £ 
Q10 How long does it take to visit the surgery and return home again?
place a cross in one box only
up to 30 minutes 30 minutes to 1 hour
l to 2 hours 3 to 4 hours 
5 to 6 hours longer than 6 hours 
Q11 Since being referred to the specialist for your child’s health problem did you have to buy anything
special? (e.g. clothing, foods, dressings)
Yes No
How much to the nearest pound did you have to spend? £ 
What did you buy?
Q12 Did you, or anyone accompanying you, have to take time off work?
Yes If Yes, please complete Q13
No If No, please go to Q14
Q13 Did either you or your companion lose any pay?
Yes If yes fill in how much below to the nearest £, if no carry on to the next question
No
You £ 
Your companion £ 
Q14 Did you, or anyone accompanying you, take annual leave in order to attend your child’s
appointment with the specialist?
you your companion
Yes
No
Q15 Did you, or anyone accompanying you, have to miss any activity or routine responsibility, other than
work, in order to attend your child’s appointment?
Yes If ‘Yes’, please cross the appropriate box below
No If ‘No’ go to Ql6
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a social occasion or pastime
picking up or dropping off children at school
other
Please specify other in box
Q16 If you, or a person attending with you, had to make special arrangements for childcare did it cost
you anything?
Yes please tell us to the nearest how much in the boxes £ 
No If you answered No please go to the next question
Q17 As a result of your child seeing the specialist, was your child Please place a cross in all boxes that apply
given a prescription
put on a waiting list for surgery
discharged or told the specialist did not need to see you again
given a further appointment to see the specialist
sent for complementary medicine (e.g. osteopathy, acupuncture)
sent for an x-ray, scan or other test or examination, given injections, given bandages
sent for therapy (e.g. physiotherapy)
other please specify other in box below
Q18 If you have any comments about the consultation, write them in the box below continue overleaf if
required
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Patient Questionnaire 3 (Adult)
Please do not write your name anywhere on this questionnaire.
All information provided is strictly confidential. 
Please ensure this questionnaire is completed only by the patient to whom the letter was sent. If this is
not possible it should be filled in with a relative or carer.
Please answer all the questions in the correct order by placing a cross in the appropriate box(es) like 
this …. 
Begin with the question at the top of the next page.
Thank you very much for your help.
Now we want to ask you about your health in the last 4 weeks. This information will help keep track of how you feel
and how well you are able to do your usual activities. Please answer every question by marking one box. If you are
unsure about how to answer, please give the best answer you can.
Q2 In general would you say your health is: (Please put a cross in one box)
Excellent
Very good
Good
Fair
Poor
Q3 The following questions are about activities you might do during a typical day. Does your health now
limit you in these activities? If so, how much? (Please put a cross in one box on each line)
Moderate activities, lifting or carrying shopping, pushing a vacuum cleaner or playing golf
Yes, limited a lot Yes, limited a little No, not limited at all
Climbing several flights of stairs
Yes, limited a lot Yes, limited a little No, not limited at all
✕
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Appendix 6
Patient questionnaire 3 (Adult and Child)Q4 During the past 4 weeks, have you had any of the following problems with your work or other regular
daily activities as a result of your physical health? (Please put a cross in one box on each line)
Accomplished less than you would like Yes No
Were limited in the kind of work or other activities Yes No
Q5 During the past 4 weeks, have you had any of the following problems with your work or other regular
daily activities as a result of any emotional problems (such as feeling depressed or anxious)? (Please put a
cross in one box on each line)
Accomplished less than you would like Yes No
Didn’t do work or other activities as carefully as usual Yes No
Q6 During the past 4 weeks, how much did pain interfere with your normal work (including both work
outside the home and housework)? (Please put a cross in one box)
Not at all A little bit Moderately Quite a bit
Extremely
The next questions are about how you feel and how things have been with you during the past 4 weeks. For each
question, please give the one answer that comes closest to the way you have been feeling.
Q7 How much of the time during the past week … (Please put a cross in one box on each line)
All of  Most of  A good bit  Some of  A little of  None of 
the time the time of the time the time the time the time
Have you felt calm and peaceful?
Did you have a lot of energy?
Have you felt downhearted and low?
Have you felt a happy person?
Q8 During the past 4 weeks, how much of the time has your physical health or emotional problems
interfered with your social activities (like visiting friends and relatives)?
(Please put a cross in one box) 
All of the time Most of the time Some of the time
A little of the time None of the time
Q9 Have you in the past six months received a home visit from a nurse?
Yes No Don’t know
Q10 If yes, how many times did the nurse visit?
1 2–3 4–5 5–10 More than 10
Don’t know 
Q11 Have you in the past six months received a visit from a health visitor?
Yes No Don’t know
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1 2–3 4–5 5–10 More than 10
Don’t know 
Q13 Have you attended accident & emergency or been admitted to any hospital in the last six months?
Yes If ‘yes’ please state which hospital(s) in the box below
No
Q14 Have you attended any hospital as an outpatient in the last six months?
Yes If ‘yes’ please state which hospital(s) in the box below
No
Please make any additional comments below ….
This questionnaire includes the SF-12™ Health Survey, item numbers 8 to 14 in this questionnaire,
reproduced with permission of the Medical Outcomes Trust, Copyright © 1994 The Health Institute;
New England Medical Center.
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Patient Questionnaire 3 (Child)
Please do not write your name anywhere on this questionnaire. 
All information provided is strictly confidential.
This questionnaire should be completed by the parent or guardian.
Please answer all the questions in the correct order by placing a cross in the appropriate box(es) like this
… 
Begin with Q2. Thank you very much for your help.
This section asks about your child’s health and well being. Your individual answers will not be shared with anyone.
Certain questions may look alike but each one is different. Some questions ask about problems your child may not have.
That’s great, but it’s important for us to know. Please answer each question. There are no right or wrong answers. If
you are unsure how to answer a question, please give the best answer you can and make a comment in the margin. All
comments will be read, so please feel free to make as many as you wish.
Q2 In general would you say your child’s health is: (Please put a cross in one box)
Excellent Very good Good Fair Poor
Q3 During the past four weeks, has your child been limited in any of the following activities due to
health problems? (place a cross in one box on each line)
Yes, limited  Yes, limited  Yes, limited  No, not 
a lot some a little limited
Doing things that take a lot of energy, such as 
playing soccer or running?
Doing things that take some energy, such as 
riding a bike or skating?
Bending, lifting or stooping?
Q4 During the past four weeks, has your child been limited in the AMOUNT of time he/she could spend
on schoolwork or activities with friends due to EMOTIONAL difficulties or problems with his/her
BEHAVIOUR? (place a cross in one box only)
Yes, limited a lot Yes, limited some Yes, limited a little
No, not limited
Q5 During the past four weeks, has your child been limited in the KIND of schoolwork or activities
he/she could do with friends due to problems with his/her PHYSICAL health?
(place a cross in one box only)
Yes, limited a lot Yes, limited some Yes, limited a little
No, not limited
✕
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None of  Once or  A few times Fairly often Very often Every or 
the time twice almost every day
Below is a list of items that describe children’s behaviour or problems they sometimes have.
Q7 How often during the past four weeks did each of the following statements describe your child?
(please place a cross in one box on each line)
Very often Fairly often Sometimes Almost never Never
Argued a lot 
Had difficulty concentrating or 
paying attention
Lied or cheated 
Q8 Compared to other children your child’s age, in general would you say his/her behaviour is:
Excellent
Very good
Good
Fair
Poor
Q9 During the past four weeks how much of the time do you think your child:
(please place a cross in one box on each line)
All of  Most of  Some of  A little of  None of 
the time the time the time the time the time
Felt lonely?
Acted nervous?
Acted bothered or upset?
The following ask about your child’s satisfaction with self, school and others. It may be helpful if you keep in mind how
other children your child’s age might feel about these areas.
Q10 During the past four weeks, how satisfied do you think your child has felt about:
(please place a cross in one box on each line)
Very satisfied Somewhat  Neither satisfied  Somewhat  Very 
satisfied or dissatisfied dissatisfied dissatisfied
his/her school ability? 
his/her friendships? 
his/her life overall?
Health Technology Assessment 2004; Vol. 8: No. 50
99
© Queen’s Printer and Controller of HMSO 2004. All rights reserved.Q11 How true or false is the statement for your child? (please place a cross in one box on each line)
Definitely  Mostly Don’t Mostly  Definitely 
true true know false false
My child seems to be less healthy than 
other children I know
My child has never been seriously ill 
I worry about my child’s health more 
than other people worry about 
their children’s
Q12 Compared to one year ago, how would you rate your child’s health?
Much better now than 1 year ago
Somewhat better than 1 year ago
About the same now as 1 year ago
Somewhat worse now than 1 year ago
Much worse now than 1 year ago
Q13 During the past 4 weeks, how MUCH emotional worry or concern did each of the following cause
YOU? (please place a cross in one box on each line)
None at all A little bit Some Quite a bit A lot
Your child’s physical health 
Your child’s emotional well being or behaviour
Q14 During the past 4 weeks, were you LIMITED in the amount of time YOU have for your own needs
because of: (please place a cross in one box on each line)
None at all A little bit Some Quite a bit A lot
Your child’s physical health?
Your child’s emotional well being or behaviour?
Q15 During the past 4 weeks, how often has your child’s health or behaviour (please place a cross in one box
on each line)
Very often Fairly often Sometimes Almost  Never
never
Limited the types of activities you could 
do as a family?
Interrupted various everyday family activities 
(eating meals, watching TV)?
Q16 Sometimes families may have difficulty getting along with one another. They do not always agree
and they may get angry. In general, how often would you rate your family’s ability to get along with one
another?
Excellent
Very good 
Good
Fair
Poor
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child has any of the following conditions? (please place a cross in one box on each line)
Yes No
Anxiety problems
Asthma
Attentional problems
Behavioural problems
Chronic allergies or sinus trouble
Chronic orthopaedic, bone or joint problems
Chronic respiratory, lung or breathing trouble (NOT ASTHMA)
Chronic rheumatic disease
Depression
Developmental delay or learning difficulties
Diabetes
Epilepsy (seizure disorder)
Hearing impairment or deafness
Learning problems
Sleep disturbance
Speech problems
Vision problems
Q18 Does your child have any chronic medical condition that is affecting what they do or how they feel?
Yes No
(Please describe in box below)
Q19 Has your child attended or been admitted to any hospital in the last six months?
Yes If ‘yes’ please state which hospital(s) in the box below
No
Q20 Have you in the past six months received a visit from a health visitor?
Yes No Don’t know
Q21 If yes, how many times did the nurse visit?
1 2–3 4–5 5–10 More than 10
Don’t know 
Q22 Has your child attended any hospital as an out-patient in the last six months?
Yes No
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Access to the system
In order to carry out the data collection exercise it
is necessary to be given high-level access to the
practice computer system. 
What is needed in advance
A list of trial patients from the GP practice where
data are being collected. This allows data
collection to be limited to those patients in the
trial who, by virtue of their participation, have
given their consent. It is also useful to have their
date of birth and possibly their address for cases
where there may be ambiguity about correct
patient identification (e.g. if the name is shared
with another patient at the practice). The person
collecting the data should also take a form where
they can record each patient’s practice ID against
their trial ID. Floppy disks are needed to save
collected data.
Creating a ‘tag’
This is done to identify patients in the practice
who are participating in the trial. A code (field) is
created in EMIS, which can be used to identify
patients in the virtual outreach trial. Data
collection is then limited to these patients. 
  MAIN MENU
  SELECT: DT Dictionaries and templates
  SELECT: C Codes/Templates/Protocols
  SELECT: M Advanced code management
  SELECT: F Create a new code
  SELECT: J Administration
  F4 See note on function keys
  SELECT: B Research
  <Insert> Insert key on keyboard
  ENTER NEW RUBRIC: ‘Pt in Telemed Trial’
Text identifier for code
  SELECT: C Just a code
  1st Synonym: VO1
Tagging a patient
  MAIN MENU
  SELECT: MR Medical records
Which patient?
Type in the patient’s surname and choose the
correct patient from the list of patients sharing
that surname. Where a surname is common it is
often better to search on date of birth.
  SELECT: A Add data
  ENTRY: VO1 <RETURN>
  TEXT: <RETURN>
  ENTER AS PROBLEM (Y/N):  N is default
N <RETURN>
  F1
  F5
Repeat the above steps until all patients have been
tagged.
Searching
  Main Menu
  SELECT: ST Search and statistics
  SELECT: B Patient searches
  SELECT: A Build and perform a new
search
  SELECT: B Perform search on all
patients, including those
who have left/died
  SELECT: A Add feature
  SELECT: CC Classification codes
  ENTRY: VO1
<RETURN>
  <RETURN> To accept
  SELECT: A There will be no date range
applied to the search
  ENTRY: N Include currently active
problems only? (Y/N)
  SELECT: A Shared
  <RETURN>
  ENTRY: Y Are these features correct?
(Y/N)
  ENTRY: Search title (e.g. vo1 14.5.2001)
<RETURN>
  ENTRY: 2 Select directory to store
search (one-off search file)
  ENTRY: Y Do you wish to run the
search now? (Y/N) 
When the search has been performed and named,
a new menu offers a number of options.
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Once a search has been performed it is possible to
repeat it (using the name it has been given).
Search reports
Two search reports are required for the analysis of
prescription data. First, a report of patients’ names
and addresses that allows practice IDs to be
matched to trial IDs. The cost data are obtained
via the prescription cost report. For this report, a
date range needs to be set: the start date should
be 6 months before the earliest patient’s index
consultation and the end date should be today’s
date (or the day before if EMIS does not allow
this). This report takes several minutes to
generate.
  Patient Searches menu
  SELECT: S Search results
  ENTRY: 2 One-off search file
  ENTRY: Number corresponding to search title
  SELECT: B Names and addresses 
  SELECT: 8 Save to disk (text with
layout)
Default directory is: C:\ESPOOL\DEFAULT.txt
Change to: A:\surgery name.txt
If the search is being undertaken at a terminal
other than the practice server, then it may not be
possible to save directly to a floppy disk. Saving to
the clipboard and pasting into Microsoft Word® or
Microsoft WordPad® is an acceptable alternative.
  Patient Searches menu
  SELECT: S Search results
  ENTRY: 2 One-off search file
  ENTRY: Number corresponding to search title
  SELECT: J Prescription cost report
  SELECT: R Run report and export
to disk
  ENTRY: set start date (e.g. 28.09.1998) 
Default directory is: C:\ESPOOL\DEFAULT.csv
Change to: A:\surgery name.csv
This file can then be exported using the CSV
(comma separated variable file) or Excel format. If
difficulty is experienced in setting the correct
filepath for a floppy, and/or locating the file on
the local hard drive, the data can be saved to the
clipboard. A clipboard file can then be saved on
the local hard drive and exported to a floppy disk.
The contents of this file can then be imported into
a Microsoft Excel file.
Notes on function keys
F1 BACK A SCREEN
F2 FIND A CODE
F4 ‘FIND’ KEY
F5 CHANGE PATIENTLondon
Hospital Specialists
Mr Mahmoud Al-Akraa
Dr Pierre Bouloux
Mr Tim Briggs
Dr Owen Epstein
Mr Nick Garlick
Mr Nick Goddard
Dr Inam Haq
Mr Amir Kaisary
Mr Robert Morgan
Mr Robert Quiney
Mr Mike Stearns
Dr Roger Wolman
Hospital Secretaries
Ms Alison Bell
Ms Marva Brown
Ms Colette Durcan
Ms Liz Scott
Ms Lisa Thane
Ms Sylvie Vingoe
Ms Norma White
Hospital Nurses
Ms Margaret Cummings
Ms Anna-Maria Kennedy
Ms Nina Shaw
Mr Nick Simmonds
Ms Geetha Somrah
Hospital Receptionists
Ms Ann Goodall
Ms Mary Herman
Ms Coretta Hyatt
Ms Beth Jacobs
Ms Phyl Odd
Other Hospital Staff
Mr Steve Ashmore
Ms Jill Brook
Ms Jacki Edwards
Mr Peter Goulton
Ms Bernadette Lobo
Ms Angela Mcguire
Ms Rachel Ryan
Ms Sonia Summerbell
General Practitioners
Dr Miranda Abraham
Dr Rajnikant Acharya
Dr N Andrawis
Dr Eric Ansell
Dr A Antoniou
Dr Nicky Beck
Dr Annette Bendor
Dr John Bentley
Dr Paul Blom
Dr Hoda Botros
Dr Surendar Brar
Dr Helen Bygrave
Dr Claire Chalmers-Watson
Dr Harry Chester
Dr Caroline Crockard
Dr Sarah Davey
Dr Cristina Davis
Dr Charles Edmondson
Dr Martin Foley
Dr Samantha Foster
Dr Karen Fraser
Dr Barbara Frosh
Dr Brian Golden
Dr Andrew Goodstone
Dr Nicholas Graham
Dr Stephen Graham
Dr Tina Grimble
Dr Lucia Grun
Dr Helen Halpern
Dr Clare Halsted
Dr Jane Higgins
Dr Simon Hodes
Dr Kathy Hoffman
Dr John Horton
Dr Alexis Ingram
Dr Lesley Isenberg
Dr Rhian Jones
Dr T Kelly
Dr Eunice Laleye
Dr Jane Lim
Dr Julia Lim
Dr Doris Lister
Dr Vivienne Manheim
Dr Claire Manktelow
Dr Margaret McCollum
Dr Kokila Mehta
Dr Richard Mendall
Dr Sarah Morgan
Dr Irwin Nazareth
Dr Helen Parkes
Dr Sarah Robins
Dr Peter Rudge
Dr Mahesh Saini
Dr Jeremy Sandford
Dr Hilary Shaw
Dr Jonathan Sheldon
Dr Joe Slesenger
Dr Charlotte Smailes
Dr Liam Smeeth
Dr Sarah Smith
Dr Teresa Smith
Dr Peter Soutter
Dr Robert Speight
Dr Thomas Strommer
Dr Andrew Stuart
Dr Barry Subel
Dr David Thompson
Dr D Twena
Dr Tony Uzoka
Dr Paul Wallace
Dr Adrian N Wayne
Dr Mary Windle
Dr Paul Wiseman
Dr Stuart Wolfman
General Practice Staff
Ms Maureen Aldridge
Ms Pauline Atkinson
Mr Michael Cahalan
Ms Theresa Callum
Mrs Beverly Clark
Ms Joan Costello
Ms Jane Davis
Ms Pauline Dudman
Ms Gail Green
Ms Tracey Grossman
Ms Chris Hayward
Mr Nick Hooker
Ms Yvonne Less
Mr Mike Mair
Ms Maura McAssery
Mr Michael Morton
Ms Cindy O’Garo
Ms Ethel Orr
Mr John Orr
Ms Jill Stephens
Ms Virginia Woods
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Staff who participated in the trialShrewsbury
Hospital Specialists
Mr Andrew Hay
Dr David Maxton
Mr Bill Neil, Consultant 
Dr Simon Nightingale
Dr Warren Perks
Mr Andrew Prichard
Dr Mark Smith
Dr Bob Wilson
Outpatient Department
Nursing staff
Medical Secretaries 
Appointments and Medical
Records staff 
Members of the IT Group 
General Practitioners 
(by practice)
Bishops Castle
Dr John Campbell
Dr Adrian Fairbanks
Dr Nick Howell
Dr Adrian Penny
Dr Clare Stanford
Caxton Surgery, Oswestry
Dr Michael Arthur
Dr David Campbell
Dr Alastair Mackereth
Dr Paul Middleton
Dr Hilary Rees
Clive
Dr John Ballantyne
Dr Julia Bennett
Dr Geoff Davies
Church Stretton
Dr Jonathan Beach
Dr Jenny Howard
Dr Steve Novick
Dr Timothy Parker
Dr Karen Robinson
Dr Rachel Taylor
Dr Charles West
Dr Deborah West
Craven Arms
Dr David Appleby
Dr Philippa Winter
Knighton
Dr Kevin Howcroft
Dr Sue Lambert
Llanfair Caereinion
Dr Anthony Evans
Dr Alun Jones-Evans
Dr Lesley Milne
Dr Gillian O’Dwyer
Dr Patrick O’Dwyer
Llanfyllin
Dr Huw Evans
Dr Richard Griffiths
Dr Marcia Hancorn
Dr Peter Jones
Dr Melanie Plant
Dr Adrian Weston
Montgomery
Dr Simon Currin
Dr Donna Griffiths
Dr Patricia Lindsay
Dr Ainsley Reid
Dr Ann Welton
Dr John Wynn-Jones
Newtown
Dr Richard Evans
Dr Steve James
Dr Margaret Jones
Dr Tim McVey
Dr Chris Nevill
Dr Alan Porter
Dr Michael Wilson
Pontesbury
Dr Steve Edmunds
Dr Helen Hawkridge
Dr Julian Povey
Ty Maen, Oswestry
Dr Wendy Dyke
Dr David Loveday
Dr Ray McMurray
Dr Anthony Treasure
Dr Helen Willows
Willow Street, Oswestry
Dr Tim Breese
Dr Anthony St John Taylor
Worthen
Dr Tim Watson
Practice Managers and other
practice administrative and 
support staff
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